AgroFresh Solutions (AGFS) 10-Q 10 Nov 21 2021 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Sep. 30, 2021	Oct. 27, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2021
Document Transition Report	false
Entity File Number	001-36316
Entity Registrant Name	AgroFresh Solutions, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	46-4007249
Entity Address, Address Line One	510-530 Walnut Street, Suite 1350
Entity Address, City or Town	Philadelphia
Entity Address, State or Province	PA
Entity Address, Postal Zip Code	19106
City Area Code	267
Local Phone Number	317-9139
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	AGFS
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		52,344,685
Entity Central Index Key	0001592016
Amendment Flag	false
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31

UNAUDITED CONDENSED CONSOLIDATE

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Current Assets:
Cash and cash equivalents	$ 43,322	$ 50,030
Accounts receivable, net of allowance for doubtful accounts of $2,205 and $2,061, respectively	59,289	63,204
Inventories	21,334	24,579
Other current assets	23,431	17,219
Total Current Assets	147,376	155,032
Property and equipment, net	11,941	12,432
Goodwill	6,569	6,925
Intangible assets, net	557,386	589,201
Deferred income tax assets	8,523	9,699
Other assets	11,010	12,494
TOTAL ASSETS	742,805	785,783
Current Liabilities:
Accounts payable	14,255	19,634
Current portion of long-term debt	3,326	3,378
Income taxes payable	3,259	3,471
Accrued expenses and other current liabilities	28,270	25,976
Total Current Liabilities	49,110	52,459
Long-term debt	254,596	264,491
Other noncurrent liabilities	6,443	6,432
Deferred income tax liabilities	38,336	37,834
Total Liabilities	348,485	361,216
Commitments and contingencies (see Note 20)
Series B convertible preferred stock, par value $0.0001; 150 shares authorized and designated and 145 shares outstanding at September 30, 2021, and 150 shares authorized, designated and outstanding at December 31, 2020	147,008	143,728
Redeemable non-controlling interest	8,005	8,446
Stockholders’ Equity:
Common stock, par value $0.0001; 400,000 shares authorized, 53,000 and 53,092 shares issued and 52,339 and 52,431 outstanding at September 30, 2021 and December 31, 2020, respectively	5	5
Preferred stock, par value $0.0001; 0.001 share authorized and outstanding at September 30, 2021 and December 31, 2020	0	0
Treasury stock, par value $0.0001; 661 shares at September 30, 2021 and December 31, 2020	(3,885)	(3,885)
Additional paid-in capital	535,612	552,776
Accumulated deficit	(252,188)	(244,836)
Accumulated other comprehensive loss	(40,237)	(31,667)
Total Stockholders' Equity	239,307	272,393
TOTAL LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS' EQUITY	$ 742,805	$ 785,783

UNAUDITED CONDENSED CONSOLIDA_2

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Allowance for doubtful accounts	$ 2,205	$ 2,061
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	400,000,000	400,000,000
Common stock, shares issued (in shares)	53,000,000	53,092,000
Common stock, shares outstanding (in shares)	52,339,000	52,431,000
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	1	1
Preferred stock, shares outstanding (in shares)	1	1
Series B Convertible Stock
Series B convertible preferred stock par value (in dollars per share)	$ 0.0001	$ 0.0001
Series B convertible preferred stock, shares authorized (in shares)	150,000	150,000
Series B convertible preferred stock, shares issued (in shares)	150,000	150,000
Series B convertible preferred stock, shares outstanding (in shares)	145,000	150,000
Treasury Stock
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Treasury stock (in shares)	661,000	661,000

UNAUDITED CONDENSED CONSOLIDA_3

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Net sales	$ 49,178	$ 52,770	$ 110,094	$ 105,775
Cost of sales (excluding amortization, shown separately below)	15,035	13,511	32,453	28,492
Gross Profit	34,143	39,259	77,641	77,283
Research and development expenses	3,329	2,852	10,123	8,389
Selling, general and administrative expenses	12,282	13,494	39,453	39,925
Amortization of intangibles	10,830	10,973	32,092	32,866
Grant income	0	0	0	(2,974)
Operating income (loss)	7,702	11,940	(4,027)	(923)
Other (expense) income	(299)	96	14,053	1,596
Debt modification and extinguishment expenses	0	(5,028)	0	(5,028)
(Loss) gain on foreign currency exchange	(918)	1,390	436	2,466
Interest expense, net	(5,465)	(4,922)	(16,571)	(18,401)
Income (loss) before income taxes	1,020	3,476	(6,109)	(20,290)
Income taxes expense	208	33,214	2,175	30,013
Net income (loss) including non-controlling interest	812	(29,738)	(8,284)	(50,303)
Less: Net (loss) income attributable to non-controlling interests	(182)	315	(441)	348
Net income (loss) attributable to AgroFresh Solutions, Inc.	994	(30,053)	(7,843)	(50,651)
Less: Dividends on convertible preferred stock	6,248	4,400	18,580	4,400
Net loss attributable to AgroFresh Solutions, Inc. common stockholders	$ (5,254)	$ (34,453)	$ (26,423)	$ (55,051)
Loss per share of common shares:
Basic (in dollars per share)	$ (0.10)	$ (0.68)	$ (0.51)	$ (1.08)
Diluted (in dollars per share)	$ (0.10)	$ (0.68)	$ (0.51)	$ (1.08)
Weighted average shares of common stock outstanding:
Basic (in shares)	51,583,000	51,002,000	51,323,000	50,766,000
Diluted (in shares)	51,583,000	51,002,000	51,323,000	50,766,000

UNAUDITED CONDENSED CONSOLIDA_4

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 812	$ (29,738)	$ (8,284)	$ (50,303)
Other comprehensive (loss) income:
Foreign currency translation adjustments	(2,413)	296	(8,570)	(8,389)
Unrealized gain (loss) on hedging activity, net of tax of $—, $61, $— and ($81), respectively	0	229	0	(304)
Recognition of gain on hedging activity reclassified to net loss, net of tax of $—, ($239), $— and ($398), respectively	0	(858)	0	(1,411)
Comprehensive loss, net of tax	$ (1,601)	$ (30,071)	$ (16,854)	$ (60,407)

UNAUDITED CONDENSED CONSOLIDA_5

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Statement of Comprehensive Income [Abstract]
Unrealized gain on hedging activity, tax expense (benefit)	$ 0	$ 61	$ 0	$ (81)
Realized gain on hedging activity reclassified to net loss, tax	$ 0	$ (239)	$ 0	$ (398)

UNAUDITED CONDENSED CONSOLIDA_6

UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Preferred Stock	Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Gain (Loss)
Beginning balance (in shares) at Dec. 31, 2019		0	51,840
Beginning balance at Dec. 31, 2019	$ 333,686	$ 0	$ 5	$ (3,885)	$ 560,890	$ (192,264)	$ (31,060)
Increase (Decrease) in Stockholders' Equity
Stock-based compensation	2,473				2,473
Issuance of stock, net of forfeitures (in shares)			(1,179)
Shares withheld for taxes (in shares)			(48)
Shares withheld for taxes	(239)				(239)
Issuance of common stock under employee stock purchase plan (in shares)			84
Issuance of common stock under employee stock purchase plan	197				197
Convertible preferred dividend	(4,400)				(4,400)
Adjustment of NCI to redemption value					(1,205)	1,205
Net loss attributable to AgroFresh Solutions, Inc.	(50,651)					(50,651)
Comprehensive loss	(10,104)						(10,104)
Ending balance (in shares) at Sep. 30, 2020		0	53,055
Ending balance at Sep. 30, 2020	270,962	$ 0	$ 5	(3,885)	557,716	(241,710)	(41,164)
Beginning balance (in shares) at Dec. 31, 2019		0	51,840
Beginning balance at Dec. 31, 2019	333,686	$ 0	$ 5	(3,885)	560,890	(192,264)	(31,060)
Increase (Decrease) in Stockholders' Equity
Adjustment of NCI to redemption value	1,139
Ending balance (in shares) at Dec. 31, 2020		0	53,092
Ending balance at Dec. 31, 2020	272,393	$ 0	$ 5	(3,885)	552,776	(244,836)	(31,667)
Beginning balance (in shares) at Jun. 30, 2020		0	52,875
Beginning balance at Jun. 30, 2020	304,895	$ 0	$ 5	(3,885)	562,072	(212,466)	(40,831)
Increase (Decrease) in Stockholders' Equity
Stock-based compensation	872				872
Issuance of stock, net of forfeitures (in shares)			(187)
Shares withheld for taxes (in shares)			(7)
Shares withheld for taxes	(19)				(19)
Convertible preferred dividend	(4,400)				(4,400)
Adjustment of NCI to redemption value					(809)	809
Net loss attributable to AgroFresh Solutions, Inc.	(30,053)					(30,053)
Comprehensive loss	(333)						(333)
Ending balance (in shares) at Sep. 30, 2020		0	53,055
Ending balance at Sep. 30, 2020	270,962	$ 0	$ 5	(3,885)	557,716	(241,710)	(41,164)
Beginning balance (in shares) at Dec. 31, 2020		0	53,092
Beginning balance at Dec. 31, 2020	272,393	$ 0	$ 5	(3,885)	552,776	(244,836)	(31,667)
Increase (Decrease) in Stockholders' Equity
Stock-based compensation	2,031				2,031
Issuance of stock, net of forfeitures (in shares)			53
Shares withheld for taxes (in shares)			(131)
Shares withheld for taxes	(287)				(287)
Issuance of common stock under employee stock purchase plan (in shares)			92
Issuance of common stock under employee stock purchase plan	163				163
Convertible preferred dividend	(18,580)				(18,580)
Adjustment of NCI to redemption value	491				(491)	491
Net loss attributable to AgroFresh Solutions, Inc.	(7,843)					(7,843)
Comprehensive loss	(8,570)						(8,570)
Ending balance (in shares) at Sep. 30, 2021		0	53,000
Ending balance at Sep. 30, 2021	239,307	$ 0	$ 5	(3,885)	535,612	(252,188)	(40,237)
Beginning balance (in shares) at Jun. 30, 2021		0	52,806
Beginning balance at Jun. 30, 2021	246,046	$ 0	$ 5	(3,885)	541,185	(253,435)	(37,824)
Increase (Decrease) in Stockholders' Equity
Stock-based compensation	949				949
Issuance of stock, net of forfeitures (in shares)			(204)
Shares withheld for taxes (in shares)			(10)
Shares withheld for taxes	(21)				(21)
Convertible preferred dividend	(6,248)				(6,248)
Adjustment of NCI to redemption value					(253)	253
Net loss attributable to AgroFresh Solutions, Inc.	994					994
Comprehensive loss	(2,413)						(2,413)
Ending balance (in shares) at Sep. 30, 2021		0	53,000
Ending balance at Sep. 30, 2021	$ 239,307	$ 0	$ 5	$ (3,885)	$ 535,612	$ (252,188)	$ (40,237)

UNAUDITED CONDENSED CONSOLIDA_7

UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities:
Net loss	$ (8,284)	$ (50,303)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	34,122	34,775
Stock-based compensation	2,031	2,473
Amortization of deferred financing costs	1,772	2,342
Interest income on interest rate swap	0	(1,809)
Deferred income taxes	1,198	25,443
Provision (benefit) for bad debts	216	(124)
Loss on sales of property and equipment	55	155
Changes in operating assets and liabilities:
Accounts receivable	906	(4,297)
Inventories	2,322	(2,281)
Prepaid expenses and other current assets	(7,799)	(6,784)
Accounts payable	(4,443)	(1,274)
Accrued expenses and other liabilities	3,103	2,344
Income taxes payable	(40)	2,846
Other assets and liabilities	801	(3,865)
Net cash provided by (used in) operating activities	25,960	(359)
Cash flows from investing activities:
Capital expenditures	(2,894)	(2,131)
Net cash used in investing activities	(2,894)	(2,131)
Cash flows from financing activities:
Repayment of long-term debt	(11,581)	(131,599)
Payment of preferred dividends	(9,970)	(2,200)
Payment for redemption of convertible preferred stock	(5,330)	0
Net proceeds from issuance of convertible preferred stock	0	145,490
Costs associated with issuance of convertible preferred stock	0	(7,006)
Proceeds from long-term debt	0	2,042
Payment of deferred financing costs	0	(7,988)
Proceeds from issuance of stock under employee stock purchase plan	163	259
Net cash used in financing activities	(26,718)	(1,002)
Effect of exchange rate changes on cash and cash equivalents and restricted cash	(3,056)	(1,176)
Net decrease in cash and cash equivalents	(6,708)	(4,668)
Cash and cash equivalents, beginning of period	50,030	29,817
Cash and cash equivalents, end of period	43,322	25,149
Cash paid for:
Cash paid for interest	14,822	18,381
Cash paid for income taxes	4,560	1,733
Supplemental schedule of non-cash investing and financing activities:
Accrued purchases of property and equipment	$ 116	$ 146

Description of Business

Description of Business	9 Months Ended
	Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business	Description of Business AgroFresh Solutions, Inc. (the “Company”) is a global leader in delivering innovative food preservation and waste prevention solutions for fresh produce. The Company is empowering the food industry with a range of integrated solutions designed to help growers, packers and retailers improve produce freshness and quality while reducing waste. The Company has an extensive portfolio of solutions to extend freshness across the produce supply chain from near-harvest up to the point-of-sale. These include Harvista TM for near-harvest optimization and the SmartFresh TM Quality System, the Company's flagship post-harvest freshness solutions. Additional post-harvest freshness solutions include fungicides that can be applied to meet various customer operational requirements in both foggable (ActiMist TM ) and liquid (ActiSeal TM ) delivery options. The Company has a controlling interest in Tecnidex Fruit Protection, S.A. (“Tecnidex”), a leading regional provider of post-harvest fungicides, disinfectants, coatings and packinghouse equipment for the citrus market and other crops. Beyond apples and pears, SmartFresh technology can provide ready-to-eat freshness for other fruits and vegetables including avocados, bananas, melons, tomatoes, broccoli and mangos. Additionally, LandSpring TM eases transplant shock for higher potential yields, and RipeLock TM is the Company's modified atmosphere packaging technology for fruits and vegetables. The Company has key products registered in approximately 50 countries and supports customers by protecting over 25,000 storage rooms globally. The end-markets that the Company serves are seasonal and are generally aligned with the seasonal growing patterns of the Company’s customers. For those customers growing, harvesting or storing apples and pears, the Company’s core crops, the peak season in the southern hemisphere is the first and second quarters of each year, while the peak season in the northern hemisphere is the third and fourth quarters of each year. Within each half-year period (i.e., January through June for the southern hemisphere, and July through December for the northern hemisphere) the growing season has historically occurred during both quarters. A variety of factors, including weather, may affect the timing of the growing, harvesting and storing patterns of the Company’s customers and therefore shift the consumption of the Company’s services and products between the first and second quarters primarily in the southern hemisphere or between the third and fourth quarters primarily in the northern hemisphere.

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Basis of Presentation and Summary of Significant Accounting Policies The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial information and in accordance with the rules and regulations of the Securities and Exchange Commission. These financial statements include all adjustments that are necessary for a fair presentation of the Company's condensed consolidated results of operations, financial condition and cash flows for the periods shown, including normal, recurring accruals and other items. The condensed consolidated results of operations for the interim periods presented are not necessarily indicative of results for the full year. For additional information, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report filed on Form 10-K for the year ended December 31, 2020. COVID-19 The global health crisis caused by COVID-19 and the related government actions and stay at home orders have negatively impacted economic activity and increased political instability across the globe. The outbreak could have a continued material adverse impact on economic and market conditions and trigger a period of global economic slowdown. There have been numerous obstacles presented and some localized financial impacts of the pandemic, including fluctuations in foreign currency exchange rates and customer demand and spending pattern changes. During the nine months ended September 30, 2021, the COVID-19 pandemic did not have a significant adverse impact on the Company’s results of operations. While the Company is following the requirements of governmental authorities and taking additional preventative and protective measures to ensure the safety of its workforce, including remote working arrangements and varying procedures for essential workforce, the outbreak presents some uncertainty and risk with respect to the Company and its performance and financial results. Adoption of Highly Inflationary Accounting in Argentina GAAP requires the use of highly inflationary accounting for countries whose cumulative three-year inflation rate exceeds 100 percent. The Company closely monitors the inflation data and currency volatility in Argentina, where there are multiple data sources for measuring and reporting inflation. In the second quarter of 2018, the Argentine peso rapidly devalued relative to the U.S. dollar, which along with increased inflation, indicated that the three-year cumulative inflation rate in that country exceeded 100 percent as of June 30, 2018. As a result, the Company elected to adopt highly inflationary accounting as of July 1, 2018 for its subsidiary in Argentina. Under highly inflationary accounting, the functional currency of the Company's subsidiary in Argentina became the U.S. dollar, and its income statement and balance sheet will be measured in U.S. dollars using both current and historical rates of exchange. The effect of changes in exchange rates on Argentine peso-denominated monetary assets and liabilities will be reflected in earnings. As the three-year cumulative inflation rate exceeded 100 percent as of September 30, 2021, there is no change to highly inflationary accounting. As of September 30, 2021, the Company’s subsidiary in Argentina had net assets of ($5.4) million. Net sales attributable to Argentina were approximately 5% and 6% of the Company’s consolidated net sales for the nine months ended September 30, 2021 and 2020, respectively. Disaggregation of Revenue The Company disaggregates revenue from contracts with customers into geographic region, product and timing of transfer of goods and services. The Company determined that disaggregating revenue into these categories achieves the disclosure objective of depicting how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. Revenues for the three months ended September 30, 2021 (in thousands) Region North America EMEA Latin America Asia Pacific Total Revenues Product 1-MCP based $17,677 $23,286 $781 $1,569 $43,313 Fungicides, disinfectants and coatings 917 3,182 1,283 — 5,382 Other* 127 129 180 47 483 $18,721 $26,597 $2,244 $1,616 $49,178 Pattern of Revenue Recognition Products transferred at a point in time $18,603 $26,468 $2,064 $1,583 $48,718 Services transferred over time 118 129 180 33 460 $18,721 $26,597 $2,244 $1,616 $49,178 Revenues for the three months ended September 30, 2020 (in thousands) Region North America EMEA Latin America Asia Pacific Total Revenues Product 1-MCP based $17,122 $28,906 $845 $1,165 $48,038 Fungicides, disinfectants and coatings 534 3,011 575 — 4,120 Other* 190 115 210 97 612 $17,846 $32,032 $1,630 $1,262 $52,770 Pattern of Revenue Recognition Products transferred at a point in time $17,663 $31,921 $1,420 $1,165 $52,169 Services transferred over time 183 111 210 97 601 $17,846 $32,032 $1,630 $1,262 $52,770 Revenues for the nine months ended September 30, 2021 (in thousands) Region North America EMEA Latin America Asia Pacific Total Revenues Product 1-MCP based $20,020 $34,083 $25,145 $12,745 $91,993 Fungicides, disinfectants and coatings 931 11,044 3,829 — 15,804 Other* 519 602 981 195 2,297 $21,470 $45,729 $29,955 $12,940 $110,094 Pattern of Revenue Recognition Products transferred at a point in time $20,958 $45,131 $29,416 $12,774 $108,279 Services transferred over time 512 598 539 166 1,815 $21,470 $45,729 $29,955 $12,940 $110,094 Revenues for the nine months ended September 30, 2020 (in thousands) Region North America EMEA Latin America Asia Pacific Total Revenues Product 1-MCP based $19,264 $37,223 $23,217 $11,538 $91,242 Fungicides, disinfectants and coatings 534 9,650 1,750 — 11,934 Other* 722 700 938 239 2,599 $20,520 $47,573 $25,905 $11,777 $105,775 Pattern of Revenue Recognition Products transferred at a point in time $19,823 $46,887 $25,338 $11,538 $103,586 Services transferred over time 697 686 567 239 2,189 $20,520 $47,573 $25,905 $11,777 $105,775 *Other includes FreshCloud, technical services and sales-type equipment leases related to Tecnidex. (1) North America includes the United States and Canada. (2) EMEA includes Europe, the Middle East and Africa. (3) Latin America includes Argentina, Brazil, Chile, Costa Rica, Colombia, Dominican Republic, Ecuador, Guatemala, Mexico, Peru and Uruguay. (4) Asia Pacific includes Australia, China, India, Japan, New Zealand, the Philippines, South Korea, Taiwan and Thailand. Contract Assets and Liabilities Accounting Standards Codification ("ASC") 606 Revenue from contracts with Customers requires an entity to present a revenue contract as a contract asset when the entity performs its obligations under the contract by transferring goods or services to a customer before the customer pays consideration or before payment is due. ASC 606 also requires an entity to present a revenue contract as a contract liability in instances when a customer pays consideration, or an entity has a right to an amount of consideration that is unconditional (e.g., receivable), before the entity transfers a good or service to the customer. The following table presents changes in the Company’s contract assets and liabilities during the nine months ended September 30, 2021 and the year ended December 31, 2020: (in thousands) Balance at Additions Deductions Balance at Contract assets: Unbilled revenue $1,484 11,850 (9,855) $3,479 Contract liabilities: Deferred revenue $1,474 3,761 (3,911) $1,324 (in thousands) Balance at Additions Deductions Balance at Contract assets: Unbilled revenue $1,666 13,624 (13,806) $1,484 Contract liabilities: Deferred revenue $1,175 5,348 (5,049) $1,474 The Company recognizes contract assets in the form of unbilled revenue in instances where services are performed by the Company but not billed by period end. The Company recognizes contract liabilities in the form of deferred revenue in instances where a customer pays in advance for future services to be performed by the Company. The Company generally receives payments from its customers based on standard terms and conditions. No significant changes or impairment losses occurred to contract balances during the nine months ended September 30, 2021. Amounts reclassified from unbilled revenue to accounts receivable for the nine months ended September 30, 2021 and for the year ended December 31, 2020 were $9.9 million and $13.8 million, respectively. Amounts reclassified from deferred revenue to revenue for the nine months ended September 30, 2021 and for the year ended December 31, 2020 were $3.9 million and $5.0 million, respectively. Recently Issued Accounting Standards and Pronouncements In January 2017, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2017-04, "Intangibles - Goodwill and Other", which simplifies the test for goodwill impairment. The guidance is effective for the Company beginning in the first quarter of fiscal year 2020. The Company adopted this standard on January 1, 2020. The adoption of this standard did not have a material impact on the condensed consolidated financial statements of the Company. In June 2016, the FASB issued ASU 2016-13, “Measurement of Credit Losses on Financial Instruments”, which introduces a new current expense credit loss model to measure impairment on certain types of financial instruments. This update requires an entity to use a forward-looking expected credit loss model for accounts receivables, loans, and other financial instruments. In addition, the FASB issued various amendments during 2018 and 2019 to clarify the provisions of ASU 2016-13. The standard was effective for fiscal years beginning January 1, 2020, including interim periods. The Company adopted the new guidance on January 1, 2020. The adoption of this standard did not have a material impact on the condensed consolidated financial statements of the Company. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement, which is part of the FASB disclosure framework project to improve the effectiveness of disclosures in the notes to the financial statements. The amendments in the new guidance remove, modify and add certain disclosure requirements related to fair value measurements covered in Topic 820, "Fair Value Measurement". The new standard was effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company adopted the new guidance on January 1, 2020. The adoption of this standard did not have a material impact on the notes to condensed consolidated financial statements of the Company. In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The amendments simplify the accounting for income taxes by removing certain exceptions to the general principles of Topic 740, "Income Taxes" and also improve consistent application by clarifying and amending existing guidance. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The Company adopted the new guidance on January 1, 2021. The adoption of the new guidance did not have a material impact on the condensed consolidated financial statements of the Company. In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The amendments provide optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2021
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions On June 13, 2020, in connection with the execution of the Investment Agreement (as defined in Note 15 - Series B Convertible Preferred Stock and Stockholders’ Equity), the Company, PSP AGFS Holdings, L.P. (the “Investor”) and Rohm and Haas Company ("R&H") entered into a side agreement, pursuant to which the parties agreed that if the Investor or its affiliates has the right to designate at least 50% of the total directors on the Company’s board of directors pursuant to the Investment Agreement, so long as R&H or its affiliates beneficially owns at least 20% of the Company’s outstanding common stock (on a fully diluted, “as converted” basis), the Company and the board of directors will increase the size of the board of directors by one member and the board will elect a designee selected by R&H to fill the newly-created vacancy. Such right is in addition to any right that R&H has to appoint a member of the board pursuant to its ownership of the Company’s Series A preferred stock (see Note 15 - Series B Convertible Preferred Stock and Stockholders’ Equity). During 2016, the Company made a minority investment in RipeLocker, LLC ("RipeLocker"), a company led by George Lobisser who was a director of the Company. In February 2019, the Company made a further minority investment in RipeLocker. As of and for the nine months ended September 30, 2021, there were no material amounts paid or owed to RipeLocker or Mr. Lobisser. Mr. Lobisser resigned as a director of the Company on February 18, 2021.

Inventories

Inventories	9 Months Ended
	Sep. 30, 2021
Inventory Disclosure [Abstract]
Inventories	Inventories Inventories at September 30, 2021 and December 31, 2020 consisted of the following: (in thousands) September 30, 2021 December 31, 2020 Raw material $2,926 $3,100 Work-in-process 4,567 7,079 Finished goods 13,015 13,288 Supplies 826 1,112 Total inventories $21,334 $24,579

Other Current Assets

Other Current Assets	9 Months Ended
	Sep. 30, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Other Current Assets	Other Current Assets The Company's other current assets at September 30, 2021 and December 31, 2020 consisted of the following: (in thousands) September 30, 2021 December 31, 2020 VAT receivable $10,945 $9,348 Income tax receivable 8,137 4,716 Prepaid and other current assets 4,349 3,155 Total other current assets $23,431 $17,219

Property and Equipment

Property and Equipment	9 Months Ended
	Sep. 30, 2021
Property, Plant and Equipment [Abstract]
Property and Equipment	Property and Equipment Property and equipment at September 30, 2021 and December 31, 2020 consisted of the following: (in thousands, except for useful life data) Useful life September 30, 2021 December 31, 2020 Buildings and leasehold improvements 7-20 $7,019 $6,416 Machinery & equipment 1-12 13,115 11,981 Furniture 1-12 2,964 3,031 Construction in progress 1,185 1,146 24,283 22,574 Less: accumulated depreciation (12,342) (10,142) Total property and equipment, net $11,941 $12,432

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
	Sep. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets Changes in the carrying amount of goodwill for the nine months ended September 30, 2021 and the year ended December 31, 2020 were as follows: (in thousands) September 30, 2021 December 31, 2020 Beginning balance $6,925 $6,323 Foreign currency translation (356) 602 Ending balance $6,569 $6,925 The Company’s intangible assets at September 30, 2021 and December 31, 2020 consisted of the following: September 30, 2021 December 31, 2020 (in thousands) Gross Carrying Accumulated Net Gross Carrying Accumulated Net Intangible assets with finite lives: Developed technology $798,198 ($283,880) $514,318 $798,260 ($254,629) $543,631 Customer relationships 20,145 (6,835) 13,310 19,072 (4,042) 15,030 Software 10,946 (9,965) 981 10,865 (9,693) 1,172 Trade name 3,738 (374) 3,364 — — — Other 100 (87) 13 100 (75) 25 Total intangible assets with finite lives 833,127 (301,141) 531,986 828,297 (268,439) 559,858 Intangible assets with indefinite lives: Trade name 23,400 — 23,400 27,343 — 27,343 Service provider network 2,000 — 2,000 2,000 — 2,000 Total intangible assets with indefinite lives 25,400 — 25,400 29,343 — 29,343 Total intangible assets $858,527 ($301,141) $557,386 $857,640 ($268,439) $589,201 During the three months ended September 30, 2021, the Company reclassified $3.7 million of trade name to finite-lived intangibles as the Company began marketing Tecnidex under the AgroFresh trade name. The Tecnidex trade name is still held as a defensive asset and is being amortized over its estimated useful life of 2.5 years, resulting in $0.4 million of amortization expense recognized during the three months ended September 30, 2021. At September 30, 2021, the weighted-average amortization periods remaining for developed technology, customer relationships, software, trade name and other was 13.8, 10.7, 2.1, 2.3 and 0.8 years, respectively, and the weighted-average amortization periods remaining for these finite-lived intangible assets was 13.6 years. Estimated annual amortization expense for finite-lived intangible assets subsequent to September 30, 2021 is as follows: (in thousands) Amount 2021 (remaining) $10,729 2022 42,619 2023 42,503 2024 40,845 2025 40,621 Thereafter 354,669 Total $531,986

Other Assets

Other Assets	9 Months Ended
	Sep. 30, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Other Assets	Other Assets The Company’s other assets at September 30, 2021 and December 31, 2020 consisted of the following: (in thousands) September 30, 2021 December 31, 2020 Right-of-use asset $6,066 $6,184 Long-term sales-type lease receivable 2,526 2,821 Other long-term receivable 2,418 3,489 Total other assets $11,010 $12,494 Other long-term receivable of $0.8 million was deemed uncollectible and was written off to other expense during the three months ended September 30, 2021.

Accrued and Other Current Liabi

Accrued and Other Current Liabilities	9 Months Ended
	Sep. 30, 2021
Payables and Accruals [Abstract]
Accrued and Other Current Liabilities	Accrued and Other Current Liabilities The Company’s accrued and other current liabilities at September 30, 2021 and December 31, 2020 consisted of the following: (in thousands) September 30, 2021 December 31, 2020 Accrued compensation and benefits $8,847 $7,778 Accrued taxes 8,265 6,649 Lease liability 1,614 1,708 Deferred revenue 1,324 1,474 Accrued rebates payable 2,300 390 Insurance premium financing payable — 695 Severance 912 598 Accrued interest 72 83 Other 4,936 6,601 Total accrued and other current liabilities $28,270 $25,976

Debt

Debt	9 Months Ended
	Sep. 30, 2021
Debt Disclosure [Abstract]
Debt	Debt The Company’s debt, net of unamortized deferred issuance costs, at September 30, 2021 and December 31, 2020 consisted of the following: (in thousands) September 30, 2021 December 31, 2020 Total term loan outstanding $263,188 $274,313 Unamortized deferred issuance costs (6,915) (8,588) Tecnidex loan outstanding 1,649 2,144 Less: Amounts due within one year 3,326 3,378 Total long-term debt due after one year $254,596 $264,491 Amended Credit Facility On July 27, 2020, the Company completed a comprehensive refinancing (the “ Refinancing ” ) by (i) entering into an Amended and Restated Credit Agreement (the “Amended Credit Agreement”) with the other loan parties party thereto, Bank of Montreal, as administrative agent and the lenders party thereto, and (ii) consummating the transactions contemplated by the Investment Agreement (as defined and described in Note 15 – Series B Convertible Preferred Stock and Stockholders’ Equity). The Amended Credit Agreement amends and restates in its entirety the Prior Credit Facility (defined below). The Amended Credit Agreement provides for a $25.0 million revolving credit facility (the “Amended Revolving Loan”), which matures on June 30, 2024, and a $275.0 million term credit facility (the “Amended Term Loan” and, together with the Amended Revolving Loan, the “Amended Credit Facility”), which matures on December 31, 2024. The Amended Credit Facility includes a $5.0 million swingline commitment and a $10.0 million letter of credit sub-limit. Loans under the Amended Term Loan bear interest at a rate equal to, at the Company’s option, either the Adjusted Eurodollar Rate for the interest period in effect for such borrowing plus an Applicable Rate of 6.25% per annum, or the Alternate Base Rate plus an Applicable Rate of 5.25% per annum. Loans under the Amended Revolving Loan bear interest at a rate equal to, at the Company’s option, the Adjusted Eurodollar Rate for the interest period in effect for such borrowing plus the Applicable Rate ranging from 6.25% to 6.0% per annum, based on certain ratios. The interest rate was 7.25% for the three and nine months ended September 30, 2021. The Company is also required to pay a commitment fee on the unused portion of the Amended Revolving Loan at a rate ranging from 0.5% to 0.375%, based on certain ratios. The Company is required to make mandatory prepayments of outstanding indebtedness under the Amended Credit Agreement under certain circumstances. During the three months ended March 31, 2021, a prepayment of principal of $9.1 million was made. The obligations of AgroFresh Inc., a wholly-owned subsidiary of the Company and the borrower under the Amended Credit Facility, are initially guaranteed by the Company and the Company’s wholly-owned subsidiary, AF Solutions Holdings LLC (together with AgroFresh Inc. and the Company, the “Loan Parties”) and may in the future be guaranteed by certain other domestic subsidiaries of the Company. The obligations of the Loan Parties under the Credit Agreement and other loan documents are secured, subject to customary permitted liens and other agreed upon exceptions, by a perfected security interest in all tangible and intangible assets of the Loan Parties, except for certain excluded assets, and equity interests of certain foreign subsidiaries of the Loan Parties held by the Loan Parties (subject to certain exclusions and limitations). The Refinancing was deemed a partial extinguishment of the Term Loan (as defined below) under ASC Topic No. 470-50, “Debt – Modifications and Extinguishments” (Topic No. 470), whereby $107.1 million of the $403.8 million outstanding at the time of the Refinancing was deemed an extinguishment and $296.7 million was deemed a modification of debt. As such, unamortized deferred issuance costs related to the extinguishment of $0.7 million were written off in debt modification and extinguishment expenses and the remaining $1.9 million was deferred and amortized over the term of the Amended Term Loan. In connection with the Amended Term Loan, expenses incurred related to existing lenders of $4.4 million were recognized in debt modification and extinguishment expenses. Expenses to new lenders of $1.1 million were deferred and amortized over the term of the Amended Term Loan along with $6.4 million of lender fees and issue discounts. In total, the Company deferred debt issuance costs of $7.5 million related to the Amended Term Loan, $1.9 million related to the modification of the Term Loan and $0.5 million related to the Amended Revolving Loan. The debt issuance costs associated with the Amended Term Loan were capitalized against the principal balance of the debt, and the Amended Revolving Loan costs were capitalized in Other Assets. All issuance costs will be accreted through interest expense using the effective interest method for the duration of each respective debt facility. The interest expense related to the amortization of the Amended Credit Facility debt issuance costs during the three and nine months ended September 30, 2021 was $0.6 million and $1.7 million. As of September 30, 2021 there were $6.9 million of unamortized deferred issuance costs. At September 30, 2021, there was $263.2 million outstanding under the Amended Term Loan and no balance outstanding under the Amended Revolving Loan. Due to the prepayment, an additional $0.3 million of deferred financing costs were expensed based on the portion of debt paid. At September 30, 2021, the Company evaluated the amount recorded under the Amended Term Loan and determined that the fair value was approximately $263.8 million. The fair value of the debt is based on quoted inactive market prices and is therefore classified as Level 2 within the valuation hierarchy. Certain restrictive covenants are contained in the Amended Credit Agreement, and the Company was in compliance with these covenants as of September 30, 2021. Prior Credit Facility On July 31, 2015 (the "Closing Date"), the Company consummated a business combination (the "Business Combination"), by and between the Company and The Dow Chemical Company ("Dow"), AgroFresh Inc. as the borrower and AF Solutions Holdings LLC as the guarantor, entered into a Credit Agreement with Bank of Montreal, as administrative agent (as subsequently amended prior to the Refinancing, the “Prior Credit Facility”). The Prior Credit Facility consisted of a $425.0 million term loan (the “Term Loan”), with an amortization equal to 1.00% per year, and a revolving loan facility (the “Revolving Loan”). The net proceeds of the Term Loan were used to fund a portion of the purchase price payable to Dow in connection with the Business Combination. The Revolving Loan included a $10.0 million letter-of-credit sub-facility, issuances against which reduced the available capacity for borrowing. The Term Loan had a scheduled maturity date of July 31, 2021. As discussed above, the Prior Credit Facility was refinanced on July 27, 2020, and there were no amounts outstanding as of September 30, 2021. The interest rates on borrowings under the Prior Credit Facility were either the alternate base rate plus 3.75% or LIBOR plus 4.75% per annum, with a 1.00% LIBOR floor (with step-downs in respect of borrowings under the Revolving Loan dependent upon the achievement of certain financial ratios). As of the Closing Date, the Company incurred approximately $12.9 million in debt issuance costs related to the Term Loan and $1.3 million in costs related to the Revolving Loan. The debt issuance costs associated with the Term Loan were capitalized against the principal balance of the debt, and the Revolving Loan costs were capitalized in Other Assets. The interest expense related to the amortization of the Term Loan debt issuance costs during the three and nine months ended September 30, 2020 was approximately $0.2 million, and $1.4 million, respectively. Tecnidex Debt In March 2020, Tecnidex entered into a €1.0 million loan agreement with Banco Santander, S.A., which provides funding through March 2023 at a 1.5% interest rate. In May 2020, Tecnidex entered into a €0.3 million loan agreement with BBVA, which provides funding through May 2025 at a 2.2% interest rate. In July 2020, Tecnidex entered into a €0.6 million loan agreement with Banco Santander, S.A., which provides funding through July 2025 at a 2.5% interest rate. Scheduled principal repayments of the Company's debt subsequent to September 30, 2021 are as follows: (in thousands) Amount 2021 (remaining) $806 2022 3,366 2023 3,120 2024 257,253 2025 292 Total $264,837 Interest Rate Swap The Company entered into an interest rate swap contract in August 2019 to hedge interest rate risk remaining outstanding with the Prior Credit Facility (which swap was rolled over to the Amended Credit Facility). During the three and nine months ended September 30, 2020, an unrealized gain of $0.3 million and an unrealized loss of $0.4 million was recognized, respectively, in connection with this swap. The interest rate swap contract matured on December 31, 2020. The Company entered into an interest rate swap contract in January 2018 to hedge interest rate risk associated with the Term Loan. The hedge was settled in September 2018 for $4.0 million, which was amortized through December 31, 2020, the remaining period of the original hedge. PPP Loan As part of the Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act"), the Company received a Paycheck Protection Program ("PPP") loan to offset eligible costs incurred during the period. Under the terms of the PPP, PPP loans and accrued interest are forgivable after twenty-four weeks as long as the borrower uses the loan proceeds for eligible purposes, including payroll, benefits, rent and utilities, and maintains its payroll levels. The amount of loan forgiveness would have been reduced if the borrower terminated employees or reduced salaries during the forgiveness period. The Company used the entire loan proceeds to fund its eligible payroll expenses and mortgage interest, avoiding furlough of office employees. As a result, the Company believed that it had met the PPP eligibility criteria for forgiveness and concluded that the loan represents, in substance, a government grant that is expected to be forgiven. As such, in accordance with IAS 20 “Accounting for Government Grants and Disclosure of Government Assistance” the Company recognized the entire loan amount as Grant Income during the three months ended June 30, 2020. The full amount of this loan was forgiven during the three months ended June 30, 2021.

Leases

Leases	9 Months Ended
	Sep. 30, 2021
Leases [Abstract]
Leases	Leases The Company enters into lease agreements for certain facilities and vehicles that are primarily used in the ordinary course of business. These leases are accounted for as operating leases, whereby lease expense is recognized on a straight-line basis over the term of the lease. Most leases include an option to extend or renew the lease term. The exercise of the renewal option is at the Company's discretion. The operating lease liability includes lease payments related to options to extend or renew the lease term if the Company is reasonably certain of exercising those options. The Company, in determining the present value of lease payments, uses the Company’s incremental secured borrowing rate commensurate with the term of the underlying lease. Lease expense is primarily included in general and administrative expenses in the unaudited condensed consolidated statements of operations. Additional information regarding the Company's operating leases is as follows: Three Months Ended September 30, Nine Months Ended September 30, (in thousands) 2021 2020 2021 2020 Operating Lease Cost Operating leases $546 $662 $1,649 $1,916 Short-term leases (1) 318 6 732 182 Total lease expense $864 $668 $2,381 $2,098 (1) Leases with an initial term of twelve months or less are not recorded on the balance sheet. Other information on operating leases: Nine Months Ended September 30, 2021 2020 Cash payments included in operating cash flows $1,689 $1,645 Right-of-use assets obtained in exchange for new lease $1,665 $769 Weighted average discount rate 8.39 % 9.11 % Weighted average remaining lease term in years 5.5 years 5.1 years The following table presents the contractual maturities of the Company's lease liabilities as of September 30, 2021. (in thousands) Lease Liability Remainder of 2021 $568 2022 1,974 2023 1,603 2024 941 2025 754 Thereafter 2,161 Total undiscounted lease payments 8,001 Less: present value adjustment 1,759 Operating lease liability $6,242

Other Noncurrent Liabilities

Other Noncurrent Liabilities	9 Months Ended
	Sep. 30, 2021
Liabilities, Other than Long-term Debt, Noncurrent [Abstract]
Other Noncurrent Liabilities	Other Noncurrent Liabilities The Company’s other noncurrent liabilities at September 30, 2021 and December 31, 2020 consisted of the following: (in thousands) September 30, 2021 December 31, 2020 Lease liability $4,628 $4,650 Other (1) 1,815 1,782 Total other noncurrent liabilities $6,443 $6,432 (1) Other noncurrent liabilities include long-term rebates and pension liabilities.

Severance

Severance	9 Months Ended
	Sep. 30, 2021
Compensation Related Costs [Abstract]
Severance	SeveranceSeverance expense was $0.0 million and $0.4 million for the three months ended September 30, 2021 and 2020, respectively, and $1.6 million and $0.5 million for the nine months ended September 30, 2021 and 2020, respectively. These amounts, which do not include stock compensation expense, were recorded in selling, general and administrative expense in the unaudited condensed consolidated statements of operations. As of September 30, 2021 and December 31, 2020, the Company had a $0.9 million and $0.6 million severance liability, respectively.

Redeemable Non-Controlling Inte

Redeemable Non-Controlling Interest	9 Months Ended
	Sep. 30, 2021
Noncontrolling Interest [Abstract]
Redeemable Non-Controlling Interest	Redeemable Non-Controlling Interest On November 7, 2017, the Company entered into a definitive agreement to acquire a controlling-interest in Tecnidex. The transaction was closed on December 1, 2017. At the effective date of the acquisition, the Company acquired 75% of the outstanding capital stock of Tecnidex. In connection with the acquisition of Tecnidex, the Company concurrently entered into option agreements ("Option Agreement") with the Seller related to the remaining 25% equity interest. The Option Agreement permits the residual interest to be "put" by the Seller to the Company, or to allow the Company to "call" the residual interest gradually over time as outlined in the agreement. The Seller's ownership of Tecnidex represents a non-controlling interest ("NCI") to the Company, which is classified outside of stockholders' equity as the option of the Seller is redeemable. As of September 30, 2021 the carrying amount of the NCI was $8.0 million in the unaudited condensed consolidated balance sheet. Any changes in the redemption value of the NCI are included as an adjustment to Additional paid-in capital on the balance sheet. The following table summarizes the changes to the Company's Redeemable non-controlling interest. (in thousands) September 30, 2021 December 31, 2020 Beginning balance ($8,446) ($7,701) Net loss attributable to redeemable non-controlling interest 932 394 Adjustment of NCI to redemption value (491) (1,139) Ending balance ($8,005) ($8,446)

Series B Convertible Preferred

Series B Convertible Preferred Stock and Stockholders' Equity	9 Months Ended
	Sep. 30, 2021
Stockholders' Equity Note [Abstract]
Series B Convertible Preferred Stock and Stockholders' Equity	Series B Convertible Preferred Stock and Stockholders’ Equity Series B Convertible Preferred Stock On June 13, 2020, the Company entered into an Investment Agreement (the “Investment Agreement”) with the Investor, an affiliate of Paine Schwartz Partners, LLC (“PSP”), pursuant to which, subject to certain closing conditions, the Investor agreed to purchase in a private placement an aggregate of $150,000,000 of convertible preferred equity of the Company. The transaction closed on July 27, 2020 and a total of 150,000 shares of the Company’s newly-designated Series B-1 Convertible Preferred Stock, par value $0.0001 per share (the “Series B-1 Preferred Stock”), were purchased in such transaction (the “Private Placement”). On September 22, 2020, following the approval of the transactions contemplated by the Investment Agreement by the necessary regulatory body, the Company issued to the Investor, for no additional consideration, a total of 150,000 shares of the Company’s newly-designated Series B-2 Convertible Preferred Stock, par value $0.0001 per share (the “Series B-2 Preferred Stock”). On September 25, 2020 (the "Exchange Date"), the Investor elected to exchange the shares of the Company’s Series B-1 Convertible Preferred Stock and Series B-2 Preferred Stock held by it for a total of 150,000 shares of the Company’s newly-designated Series B Convertible Preferred Stock, par value $0.0001 per share (the “Series B Preferred Stock”). Accordingly, effective as of the Exchange Date, the Company issued 150,000 shares of Series B Preferred Stock to the Investor and all of the shares of Series B-1 Preferred Stock and Series B-2 Preferred Stock held by the Investor were cancelled. No shares of Series B-1 Preferred Stock or Series B-2 Preferred Stock are outstanding as of September 30, 2021. The Series B Preferred Stock ranks senior to the shares of the Company’s common stock with respect to dividend rights and rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company. The Series B Preferred Stock has a liquidation preference of $1,000 per share (the “Stated Value”). Holders of the Series B Preferred Stock are entitled to a cumulative dividend at a rate of 16% per annum, of which 50% was payable in cash and 50% was payable in kind until July 27, 2021, after which 50% is payable in cash, 37.5% is payable in kind, and the remaining 12.5% is payable in cash or in kind, at the Company’s option, subject in each case to adjustment under certain circumstances. Dividends on the Series B Preferred Stock are cumulative and payable quarterly in arrears. All dividends that are paid in kind will accrete to, and increase, the Stated Value. The applicable dividend rate is subject to increase by 2% per annum during any period that the Company is in breach of certain provisions of the applicable Certificate of Designation of the Preferred Stock. The Series B Preferred Stock has been classified as temporary equity as it may be contingently redeemable in the event of a change of control, which is outside of the Company's control. Associated with the Series B Preferred Stock, the Company paid dividends of $2.3 million in kind and $3.9 million in cash during the three months ended September 30, 2021. The Company paid dividends of $8.6 million in kind and $10.0 million in cash during the nine months ended September 30, 2021. The Company paid dividends of $2.2 million in kind and $2.2 million in cash during the three and nine months ended September 30, 2020 associated with the Series B Preferred Stock. As of September 30, 2021 and December 31, 2020, the Company had no accrued dividends. The Series B Preferred Stock is convertible into Common Stock at the election of the holder at any time at an initial conversion price of $5.00 (the “Conversion Price”). The Conversion Price is subject to customary adjustments, including for stock splits and other reorganizations affecting the Common Stock and pursuant to certain anti-dilution provisions for below market issuances. As of September 30, 2021 and December 31, 2020, the maximum number of shares of common stock that could be issued upon conversion of the outstanding shares of Series B Preferred Stock was approximately 31.7 million and 31.0 million shares, respectively. During the nine months ended September 30, 2021, the Company redeemed 4,954 shares of Series B Preferred Stock for $5.3 million. The below table outlines the change in Series B Preferred Stock during the nine months ended September 30, 2021 and the year ended December 31, 2020. Series B-1 Convertible Preferred Stock Series B-2 Convertible Preferred Stock Series B Convertible Preferred Stock (in thousands) Shares Amount Shares Amount Shares Amount Balance at December 31, 2019 — $— — $— — $— Issuance of preferred stock 150 150,000 150 — — — Exchange to Series B preferred stock (150) (150,000) (150) — 150 150,000 Issuance-related expenses — — — — — (11,516) In kind dividend — — — — — 5,244 Balance at December 31, 2020 — — — — 150 143,728 Redemption of shares — — — — (5) (5,330) In kind dividend — — — — — 8,610 Balance at September 30, 2021 — $— — $— 145 $147,008 In connection with the consummation of the Investment Agreement, the Company and the Investor entered into a Registration Rights Agreement (the “Registration Rights Agreement”), dated as of July 27, 2020. The Registration Rights Agreement provides that the Company will use its commercially reasonable efforts to prepare and file a shelf registration statement with the SEC no later than the first business day following January 27, 2022, and to use its commercially reasonable efforts to cause such shelf registration statement to be declared effective as promptly as is reasonably practicable after its filing to permit the public resale of registrable securities covered by the Registration Rights Agreement. The registrable securities generally include any shares of the Company’s common stock into which the Series B Preferred Stock is convertible, and any other securities issued or issuable with respect to any such shares of common stock by way of share split, share dividend, distribution, recapitalization, merger, exchange, replacement or similar event or otherwise. Common Stock The authorized common stock of the Company consists of 400.0 million shares with a par value of $0.0001 per share. Holders of the Company’s common stock are entitled to one vote for each share of common stock. As of September 30, 2021, there were approximately 52.3 million shares of common stock outstanding. Warrants On July 31, 2020, all outstanding warrants, consisting of warrants to purchase 16.0 million shares of the Company’s common stock outstanding at a strike price of $11.50, expired. Of the 16.0 million warrants, 9.8 million were issued as part of the units sold in the Company's initial public offering in February 2014 (1.2 million warrants were subsequently repurchased during 2015) and 6.2 million warrants were sold in a private placement at the time of such public offering. Series A Preferred Stock In connection with and as a condition to the consummation of the Business Combination, the Company issued R&H one share of Series A Preferred Stock. R&H, voting as a separate class, is entitled to appoint one director to the Company’s board of directors for so long as R&H beneficially holds 10% or more of the aggregate amount of the outstanding shares of common stock and non-voting common stock of the Company. The Series A Preferred Stock has no other rights. ATM Facility In December 2018, the Company filed a shelf registration statement (File No. 333-229002) (the “Form S-3 Shelf”) with the Securities and Exchange Commission, that became effective in February 2019. On June 25, 2020, the Company established an at-the-market offering facility (the “ATM Facility”) under the Form S-3 Shelf, with Virtu Americas LLC, acting as sales agent with support from H.C. Wainwright & Co and Roth Capital Partners. The Company’s board of directors approved sales of up to $30,000,000 maximum aggregate offering of the Company’s common stock under the ATM Facility. Effective as of August 7, 2020, the Company suspended sales under its ATM Facility, in light of the Company’s recent completion of the Refinancing and current market conditions. No sales were effected pursuant to the ATM Facility. Effective as of August 10, 2021, the ATM Facility was terminated, and no future issuances will occur under the ATM Facility.

Stock-based Compensation

Stock-based Compensation	9 Months Ended
	Sep. 30, 2021
Share-based Payment Arrangement [Abstract]
Stock-based Compensation	Stock-based Compensation The Company's stock-based compensation is in accordance with the Company's amended 2015 Incentive Compensation Plan (the “Plan”), pursuant to which the Compensation Committee of the Company is authorized to grant up to 13.7 million shares to officers and employees of the Company, in the form of equity-based awards, including time or performance based options and restricted stock. In addition, the Company may grant cash-settled awards, including stock-appreciation rights (SARs) and phantom stock awards. In June 2019, the Company's shareholders approved the 2019 Employee Stock Purchase Plan (the "ESPP"), which was effective July 1, 2019. In August 2021, the number of shares reserved for issuance under the ESPP was increased to 1.3 million. The ESPP allows eligible employees to purchase shares of common stock at a discount of up to 15% through payroll deductions of their eligible compensation, subject to any plan limitations. The ESPP provides for six-month offering periods beginning January 1 and July 1 of each year, and each offering period consists of a six-month purchase period. On each purchase date, eligible employees may purchase the Company's common stock at a price per share equal to 85% of the lesser of (1) the fair market value of the common stock on the offering date or (2) the fair market value of the common stock on the purchase date. As of September 30, 2021, 406,476 shares had been issued under the ESPP. Stock compensation expense for equity-classified and liability-classified awards was $1.0 million and $0.9 million for the three months ended September 30, 2021 and 2020, respectively. Stock compensation expense for equity-classified and liability-classified awards was $2.1 million and $2.7 million for the nine months ended September 30, 2021 and 2020, respectively. Stock compensation expense is recognized in cost of goods sold, selling, general and administrative expenses and research and development expenses. At September 30, 2021, there was $7.0 million of unrecognized compensation cost relating to outstanding unvested equity instruments expected to be recognized over the weighted average period of 2.2 years.

Earnings Per Share

Earnings Per Share	9 Months Ended
	Sep. 30, 2021
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share Basic loss per share is calculated by dividing net loss attributable to AgroFresh Solutions, Inc. common stockholders by the weighted average number of common shares outstanding for the period. The Company had a loss for the three and nine months ended September 30, 2021 and 2020. Therefore, the effects of stock-based awards including options, restricted stock, restricted stock units and warrants outstanding at September 30, 2021 and 2020, respectively, have not been included in the computation of diluted loss per share because their inclusion would have been anti-dilutive. The following is a reconciliation of the weighted-average common shares outstanding used for the computation of basic and diluted net loss per common share: Three Months Ended September 30, Nine Months Ended September 30, (in thousands) 2021 2020 2021 2020 Basic weighted-average common shares outstanding 51,583 51,002 51,323 50,766 Effect of dilutive options, restricted stock, and restricted stock units — — — — Diluted weighted-average shares outstanding 51,583 51,002 51,323 50,766 Securities that could potentially be dilutive are excluded from the computation of diluted loss per share when a loss from continuing operations exists, when the exercise price exceeds the average closing price of the Company's common stock during the period, or for contingently issued shares, if the contingency is not met at the end of the reporting period, because their inclusion would result in an anti-dilutive effect on per share amounts. The following represents the weighted average number of shares that could potentially dilute basic earnings per share in the future: Three Months Ended September 30, Nine Months Ended September 30, (in thousands) 2021 2020 2021 2020 Convertible preferred stock 31,242 21,527 30,955 7,228 Stock-based compensation awards (1) : Stock options 1,446 800 1,114 804 Restricted stock awards and restricted stock units 3,790 1,811 3,214 1,079 Warrants: Private placement warrants — 2,076 — 4,789 Public warrants — 3,310 — 7,636 (1) SARs and Phantom stocks are payable in cash so will therefore have no impact on number of shares.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2021
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The provision for income taxes consists of provisions for federal, state and foreign income taxes. The effective tax rates for the periods ended September 30, 2021 and September 30, 2020, reflect the Company’s expected tax rate on reported income (loss) from continuing operations before income tax and tax adjustments. The Company operates in a global environment with significant operations in the U.S. and various other jurisdictions outside the U.S. Accordingly, the consolidated income tax rate is a composite rate reflecting the Company’s earnings and the applicable tax rates in the various jurisdictions where the Company operates. On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act was enacted in the U.S. The CARES Act included tax changes and financial aid designed to protect the American people from the public health and economic impacts of COVID-19. The tax changes included allowing net operating losses to be carried back five years, suspending the 80% of taxable income limitation on the use of net operating losses, an increase of the EBITDA limitation on the deduction of interest expense from 30% to 50%, excluding any grant income associated with forgiven PPP loans, and the acceleration of the refund for alternative minimum tax credits granted under the 2017 Tax Cuts and Jobs Act (“TCJA”). Most significant to the Company are the modifications on the limitation on business interest deductions for tax year 2020, allowing an increase for deductible interest expense in the U.S. In addition, the grant income associated with the PPP loans was non-taxable income in the U.S. for tax year 2020. The Company's U.S. operations have incurred cumulative taxable losses through September 30, 2021. The Company’s U.S. net operating loss carry forwards and carry forwards of other tax attributes are subject to review and possible adjustment by the Internal Revenue Service and state tax authorities. The utilization of the tax attributes have become restricted because of certain cumulative changes in the ownership interest of significant shareholders over a three-year period in excess of 50%, as defined under Section 382 and Section 383 of the Internal Revenue Code of 1986, as amended, as well as similar state tax provisions. This limits the amount of the tax attributes that the Company can utilize annually to offset future taxable income or tax liabilities. The amount of the annual limitation, if any, was determined based on the value of the Company immediately prior to the ownership change. Subsequent ownership changes may further affect the limitation in future years. Please refer to Note 3 - Related Party Transactions regarding the ownership change in the quarter ended September 30, 2020. The Company completed a Section 382 study and determined the ownership change gave rise to the restrictions that will limit the realizability of certain U.S. tax attributes and built-in losses related to future intangible amortization tax deductions. These limitations apply to the corresponding tax attributes and built-in losses incurred before the ownership change. The effective tax rate for the nine months ended September 30, 2021 differs from the U.S. statutory tax rate of 21%, primarily because of changes in valuation allowance positions related to the United States and certain foreign jurisdictions, and by foreign exchange currency gains and losses, offset by certain non-taxable items. For the three months ending September 30, 2021, the decrease in tax expense from reversing some of the valuation allowance on foreign companies was almost fully offset by an increase in the valuation allowances in the United States arising from the change in control and on intercompany eliminations. The Company's effective tax rate for the three and nine months ended September 30, 2021 was 20.4% and (35.6)%, respectively, compared to the effective tax rate for the three and nine months ended September 30, 2020 of 955.5% and (147.9)%, respectively.

Segment Information

Segment Information	9 Months Ended
	Sep. 30, 2021
Segment Reporting [Abstract]
Segment Information	Segment Information The authoritative guidance for disclosures about segments of an enterprise establishes standards for reporting information about segments. It defines operating segments as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision-maker in deciding how to allocate resources and in assessing performance. We currently operate and manage our business as two operating segments. Our chief operating decision-makers allocate resources and assess performance of the business for each segment. Accordingly, we consider ourselves to have two operating and reportable segments (i) AgroFresh core and (ii) Tecnidex. AgroFresh core business is providing produce preservation and waste reduction solutions for growers and packers. Its products include SmartFresh TM , Harvista TM and FreshCloud. Tecnidex is a provider of fungicides, disinfectants and coatings. Its revenues primarily relate to sales of these products, as well as equipment, in the EMEA and Latin America regions. Our chief operating decision-makers do not evaluate operating segments using asset or liability information. The following table presents a breakdown of our revenues and gross profit based on reportable segments for the three and nine months ended September 30, 2021 and 2020. Three Months Ended September 30, Nine Months Ended September 30, (in thousands) 2021 2020 2021 2020 AgroFresh Core Revenues $44,815 $49,343 $96,438 $94,723 Gross Profit 33,078 38,283 74,843 73,080 Tecnidex Revenues 4,363 3,427 13,656 11,052 Gross Profit 1,065 976 2,798 4,203 Total Revenues $49,178 $52,770 $110,094 $105,775 Total Gross Profit $34,143 $39,259 $77,641 $77,283

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and ContingenciesThe Company is currently involved in various claims and legal actions that arise in the ordinary course of business. The Company has recorded reserves for loss contingencies based on the specific circumstances of each case. Such reserves are recorded when it is probable that a loss has been incurred as of the balance sheet date and can be reasonably estimated. Although the results of litigation and claims can never be predicted with certainty, the Company does not believe that the ultimate resolution of these actions will have a material adverse effect on the Company’s business, financial condition or results of operations. On October 14, 2019, the Company was awarded a verdict of $31.1 million in damages, related to, among other things, trade secret misappropriation and willful patent infringement, in its litigation against Decco Post-Harvest, Inc. ("Decco") and Decco's parent company, UPL Limited. The award was subsequently reduced by $18 million in connection with post-verdict review by the Court. During the three months ended March 31, 2021, the lawsuit was settled, paid and is considered closed. Purchase Commitments The Company has various purchasing contracts for contract manufacturing and research and development services which are based on the requirements of the business. Generally, the contracts are at prices not in excess of current market price and do not commit the business to obligations outside the normal customary terms for similar contracts, and these payment obligations are considered insignificant.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements Liabilities Measured at Fair Value on a Recurring Basis The following table presents the fair value of the Company's financial instruments that are measured at fair value on a recurring basis as of September 30, 2021. (in thousands) Level 3 Liability-classified stock compensation (1) $198 The following table presents the fair value of the Company's financial instruments that are measured at fair value on a recurring basis as of December 31, 2020. (in thousands) Level 3 Liability-classified stock compensation (1) $282 (1) The fair values of performance-based phantom shares granted in 2019 and 2020 were estimated using a Monte Carlo simulation pricing model with the assumptions described below: September 30, 2021 Grant date fair value $1.70 — $7.28 Risk-free interest rate 0.27% — 2.39% Expected life (years) 2.71 — 2.75 Estimated volatility factor 65.1% — 69.9% Expected dividends None There were no transfers between Level 1 and Level 2 and no transfers out of Level 3 of the fair value hierarchy during the nine months ended September 30, 2021. At September 30, 2021, the Company evaluated the amount recorded under the Amended Term Loan and determined that the fair value was approximately $263.8 million. The carrying amounts of cash and cash equivalents, accounts receivable, and accounts payable approximate fair value. Changes in Financial Instruments Measured at Level 3 Fair Value on a Recurring Basis The following table presents the changes during the periods presented in our Level 3 financial instruments that are measured at fair value on a recurring basis. (in thousands) Liability-classified stock compensation Balance, December 31, 2020 $282 Stock compensation activity (84) Balance, September 30, 2021 $198

Other Expense (Income)

Other Expense (Income)	9 Months Ended
	Sep. 30, 2021
Other Income and Expenses [Abstract]
Other Expense (Income)	Other Expense (Income) During the three months ended September 30, 2021 and 2020, the Company had other expense of $0.3 million and other income of $0.1 million, respectively. During the nine months ended September 30, 2021 and 2020, the Company had other income of $14.1 million and $1.6 million, respectively, related primarily to the receipt of proceeds from the settlement of litigation matters.

Correction of Prior Period Erro

Correction of Prior Period Errors	9 Months Ended
	Sep. 30, 2021
Accounting Changes and Error Corrections [Abstract]
Correction of Prior Period Errors	Correction of Prior Period ErrorsAs previously disclosed in Note 24 to the Company’s consolidated financial statements as of and for the year ended December 31, 2020, management of the Company identified an immaterial accounting error in the Company’s previously reported unaudited interim condensed consolidated financial statements related to the accounting for the Company’s NCI. As a result, the accompanying unaudited interim condensed consolidated financial statements and related notes hereto for the three and nine months ended September 30, 2020 have been revised to give effect to the correction of this error. The correction of this error resulted in a reclassification of the carrying value of the NCI from previously reported permanent equity to temporary equity as of September 30, 2020, and a charge to previously reported additional paid-in capital to increase the carrying value of the Redeemable NCI during the three and nine months ended September 30, 2020 by $0.8 million and $1.2 million, respectively, which has been applied as an adjustment to previously reported net (loss) income attributable to AgroFresh Solutions, Inc. in the determination of basic and fully diluted net (loss) income per share attributable to AgroFresh stockholders for the three and nine months ended September 30, 2020.

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policy)	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Basis of Presentation	The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial information and in accordance with the rules and regulations of the Securities and Exchange Commission. These financial statements include all adjustments that are necessary for a fair presentation of the Company's condensed consolidated results of operations, financial condition and cash flows for the periods shown, including normal, recurring accruals and other items. The condensed consolidated results of operations for the interim periods presented are not necessarily indicative of results for the full year. For additional information, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report filed on Form 10-K for the year ended December 31, 2020.
Adoption of Highly Inflationary Accounting in Argentina	Adoption of Highly Inflationary Accounting in Argentina GAAP requires the use of highly inflationary accounting for countries whose cumulative three-year inflation rate exceeds 100 percent. The Company closely monitors the inflation data and currency volatility in Argentina, where there are multiple data sources for measuring and reporting inflation. In the second quarter of 2018, the Argentine peso rapidly devalued relative to the U.S. dollar, which along with increased inflation, indicated that the three-year cumulative inflation rate in that country exceeded 100 percent as of June 30, 2018. As a result, the Company elected to adopt highly inflationary accounting as of July 1, 2018 for its subsidiary in Argentina. Under highly inflationary accounting, the functional currency of the Company's subsidiary in Argentina became the U.S. dollar, and its income statement and balance sheet will be measured in U.S. dollars using both current and
Disaggregation of Revenue and Contract Assets and Liabilities	Disaggregation of Revenue The Company disaggregates revenue from contracts with customers into geographic region, product and timing of transfer of goods and services. The Company determined that disaggregating revenue into these categories achieves the disclosure objective of depicting how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. Revenues for the three months ended September 30, 2021 (in thousands) Region North America EMEA Latin America Asia Pacific Total Revenues Product 1-MCP based $17,677 $23,286 $781 $1,569 $43,313 Fungicides, disinfectants and coatings 917 3,182 1,283 — 5,382 Other* 127 129 180 47 483 $18,721 $26,597 $2,244 $1,616 $49,178 Pattern of Revenue Recognition Products transferred at a point in time $18,603 $26,468 $2,064 $1,583 $48,718 Services transferred over time 118 129 180 33 460 $18,721 $26,597 $2,244 $1,616 $49,178 Revenues for the three months ended September 30, 2020 (in thousands) Region North America EMEA Latin America Asia Pacific Total Revenues Product 1-MCP based $17,122 $28,906 $845 $1,165 $48,038 Fungicides, disinfectants and coatings 534 3,011 575 — 4,120 Other* 190 115 210 97 612 $17,846 $32,032 $1,630 $1,262 $52,770 Pattern of Revenue Recognition Products transferred at a point in time $17,663 $31,921 $1,420 $1,165 $52,169 Services transferred over time 183 111 210 97 601 $17,846 $32,032 $1,630 $1,262 $52,770 Revenues for the nine months ended September 30, 2021 (in thousands) Region North America EMEA Latin America Asia Pacific Total Revenues Product 1-MCP based $20,020 $34,083 $25,145 $12,745 $91,993 Fungicides, disinfectants and coatings 931 11,044 3,829 — 15,804 Other* 519 602 981 195 2,297 $21,470 $45,729 $29,955 $12,940 $110,094 Pattern of Revenue Recognition Products transferred at a point in time $20,958 $45,131 $29,416 $12,774 $108,279 Services transferred over time 512 598 539 166 1,815 $21,470 $45,729 $29,955 $12,940 $110,094 Revenues for the nine months ended September 30, 2020 (in thousands) Region North America EMEA Latin America Asia Pacific Total Revenues Product 1-MCP based $19,264 $37,223 $23,217 $11,538 $91,242 Fungicides, disinfectants and coatings 534 9,650 1,750 — 11,934 Other* 722 700 938 239 2,599 $20,520 $47,573 $25,905 $11,777 $105,775 Pattern of Revenue Recognition Products transferred at a point in time $19,823 $46,887 $25,338 $11,538 $103,586 Services transferred over time 697 686 567 239 2,189 $20,520 $47,573 $25,905 $11,777 $105,775 *Other includes FreshCloud, technical services and sales-type equipment leases related to Tecnidex. (1) North America includes the United States and Canada. (2) EMEA includes Europe, the Middle East and Africa. (3) Latin America includes Argentina, Brazil, Chile, Costa Rica, Colombia, Dominican Republic, Ecuador, Guatemala, Mexico, Peru and Uruguay. (4) Asia Pacific includes Australia, China, India, Japan, New Zealand, the Philippines, South Korea, Taiwan and Thailand. Contract Assets and Liabilities Accounting Standards Codification ("ASC") 606 Revenue from contracts with Customers requires an entity to present a revenue contract as a contract asset when the entity performs its obligations under the contract by transferring goods or services to a customer before the customer pays consideration or before payment is due. ASC 606 also requires an entity to present a revenue contract as a contract liability in instances when a customer pays consideration, or an entity has a right to an amount of consideration that is unconditional (e.g., receivable), before the entity transfers a good or service to the customer. The following table presents changes in the Company’s contract assets and liabilities during the nine months ended September 30, 2021 and the year ended December 31, 2020: (in thousands) Balance at Additions Deductions Balance at Contract assets: Unbilled revenue $1,484 11,850 (9,855) $3,479 Contract liabilities: Deferred revenue $1,474 3,761 (3,911) $1,324 (in thousands) Balance at Additions Deductions Balance at Contract assets: Unbilled revenue $1,666 13,624 (13,806) $1,484 Contract liabilities: Deferred revenue $1,175 5,348 (5,049) $1,474
Recently Issued Accounting Standards and Pronouncements	Recently Issued Accounting Standards and Pronouncements In January 2017, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2017-04, "Intangibles - Goodwill and Other", which simplifies the test for goodwill impairment. The guidance is effective for the Company beginning in the first quarter of fiscal year 2020. The Company adopted this standard on January 1, 2020. The adoption of this standard did not have a material impact on the condensed consolidated financial statements of the Company. In June 2016, the FASB issued ASU 2016-13, “Measurement of Credit Losses on Financial Instruments”, which introduces a new current expense credit loss model to measure impairment on certain types of financial instruments. This update requires an entity to use a forward-looking expected credit loss model for accounts receivables, loans, and other financial instruments. In addition, the FASB issued various amendments during 2018 and 2019 to clarify the provisions of ASU 2016-13. The standard was effective for fiscal years beginning January 1, 2020, including interim periods. The Company adopted the new guidance on January 1, 2020. The adoption of this standard did not have a material impact on the condensed consolidated financial statements of the Company. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement, which is part of the FASB disclosure framework project to improve the effectiveness of disclosures in the notes to the financial statements. The amendments in the new guidance remove, modify and add certain disclosure requirements related to fair value measurements covered in Topic 820, "Fair Value Measurement". The new standard was effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company adopted the new guidance on January 1, 2020. The adoption of this standard did not have a material impact on the notes to condensed consolidated financial statements of the Company. In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The amendments simplify the accounting for income taxes by removing certain exceptions to the general principles of Topic 740, "Income Taxes" and also improve consistent application by clarifying and amending existing guidance. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The Company adopted the new guidance on January 1, 2021. The adoption of the new guidance did not have a material impact on the condensed consolidated financial statements of the Company. In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The amendments provide optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Schedule of disaggregated revenue	Revenues for the three months ended September 30, 2021 (in thousands) Region North America EMEA Latin America Asia Pacific Total Revenues Product 1-MCP based $17,677 $23,286 $781 $1,569 $43,313 Fungicides, disinfectants and coatings 917 3,182 1,283 — 5,382 Other* 127 129 180 47 483 $18,721 $26,597 $2,244 $1,616 $49,178 Pattern of Revenue Recognition Products transferred at a point in time $18,603 $26,468 $2,064 $1,583 $48,718 Services transferred over time 118 129 180 33 460 $18,721 $26,597 $2,244 $1,616 $49,178 Revenues for the three months ended September 30, 2020 (in thousands) Region North America EMEA Latin America Asia Pacific Total Revenues Product 1-MCP based $17,122 $28,906 $845 $1,165 $48,038 Fungicides, disinfectants and coatings 534 3,011 575 — 4,120 Other* 190 115 210 97 612 $17,846 $32,032 $1,630 $1,262 $52,770 Pattern of Revenue Recognition Products transferred at a point in time $17,663 $31,921 $1,420 $1,165 $52,169 Services transferred over time 183 111 210 97 601 $17,846 $32,032 $1,630 $1,262 $52,770 Revenues for the nine months ended September 30, 2021 (in thousands) Region North America EMEA Latin America Asia Pacific Total Revenues Product 1-MCP based $20,020 $34,083 $25,145 $12,745 $91,993 Fungicides, disinfectants and coatings 931 11,044 3,829 — 15,804 Other* 519 602 981 195 2,297 $21,470 $45,729 $29,955 $12,940 $110,094 Pattern of Revenue Recognition Products transferred at a point in time $20,958 $45,131 $29,416 $12,774 $108,279 Services transferred over time 512 598 539 166 1,815 $21,470 $45,729 $29,955 $12,940 $110,094 Revenues for the nine months ended September 30, 2020 (in thousands) Region North America EMEA Latin America Asia Pacific Total Revenues Product 1-MCP based $19,264 $37,223 $23,217 $11,538 $91,242 Fungicides, disinfectants and coatings 534 9,650 1,750 — 11,934 Other* 722 700 938 239 2,599 $20,520 $47,573 $25,905 $11,777 $105,775 Pattern of Revenue Recognition Products transferred at a point in time $19,823 $46,887 $25,338 $11,538 $103,586 Services transferred over time 697 686 567 239 2,189 $20,520 $47,573 $25,905 $11,777 $105,775 *Other includes FreshCloud, technical services and sales-type equipment leases related to Tecnidex. (1) North America includes the United States and Canada. (2) EMEA includes Europe, the Middle East and Africa. (3) Latin America includes Argentina, Brazil, Chile, Costa Rica, Colombia, Dominican Republic, Ecuador, Guatemala, Mexico, Peru and Uruguay. (4) Asia Pacific includes Australia, China, India, Japan, New Zealand, the Philippines, South Korea, Taiwan and Thailand.
Schedule of changes in contract assets and liabilities	The following table presents changes in the Company’s contract assets and liabilities during the nine months ended September 30, 2021 and the year ended December 31, 2020: (in thousands) Balance at Additions Deductions Balance at Contract assets: Unbilled revenue $1,484 11,850 (9,855) $3,479 Contract liabilities: Deferred revenue $1,474 3,761 (3,911) $1,324 (in thousands) Balance at Additions Deductions Balance at Contract assets: Unbilled revenue $1,666 13,624 (13,806) $1,484 Contract liabilities: Deferred revenue $1,175 5,348 (5,049) $1,474

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Sep. 30, 2021
Inventory Disclosure [Abstract]
Schedule of inventories	Inventories at September 30, 2021 and December 31, 2020 consisted of the following: (in thousands) September 30, 2021 December 31, 2020 Raw material $2,926 $3,100 Work-in-process 4,567 7,079 Finished goods 13,015 13,288 Supplies 826 1,112 Total inventories $21,334 $24,579

Other Current Assets (Tables)

Other Current Assets (Tables)	9 Months Ended
	Sep. 30, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of other current assets	The Company's other current assets at September 30, 2021 and December 31, 2020 consisted of the following: (in thousands) September 30, 2021 December 31, 2020 VAT receivable $10,945 $9,348 Income tax receivable 8,137 4,716 Prepaid and other current assets 4,349 3,155 Total other current assets $23,431 $17,219

Property and Equipment (Tables)

Property and Equipment (Tables)	9 Months Ended
	Sep. 30, 2021
Property, Plant and Equipment [Abstract]
Schedule of property and equipment	Property and equipment at September 30, 2021 and December 31, 2020 consisted of the following: (in thousands, except for useful life data) Useful life September 30, 2021 December 31, 2020 Buildings and leasehold improvements 7-20 $7,019 $6,416 Machinery & equipment 1-12 13,115 11,981 Furniture 1-12 2,964 3,031 Construction in progress 1,185 1,146 24,283 22,574 Less: accumulated depreciation (12,342) (10,142) Total property and equipment, net $11,941 $12,432

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of changes in the carrying amount of goodwill	Changes in the carrying amount of goodwill for the nine months ended September 30, 2021 and the year ended December 31, 2020 were as follows: (in thousands) September 30, 2021 December 31, 2020 Beginning balance $6,925 $6,323 Foreign currency translation (356) 602 Ending balance $6,569 $6,925
Schedule of other intangible assets	The Company’s intangible assets at September 30, 2021 and December 31, 2020 consisted of the following: September 30, 2021 December 31, 2020 (in thousands) Gross Carrying Accumulated Net Gross Carrying Accumulated Net Intangible assets with finite lives: Developed technology $798,198 ($283,880) $514,318 $798,260 ($254,629) $543,631 Customer relationships 20,145 (6,835) 13,310 19,072 (4,042) 15,030 Software 10,946 (9,965) 981 10,865 (9,693) 1,172 Trade name 3,738 (374) 3,364 — — — Other 100 (87) 13 100 (75) 25 Total intangible assets with finite lives 833,127 (301,141) 531,986 828,297 (268,439) 559,858 Intangible assets with indefinite lives: Trade name 23,400 — 23,400 27,343 — 27,343 Service provider network 2,000 — 2,000 2,000 — 2,000 Total intangible assets with indefinite lives 25,400 — 25,400 29,343 — 29,343 Total intangible assets $858,527 ($301,141) $557,386 $857,640 ($268,439) $589,201
Schedule of estimated annual amortization expense for finite-lived intangible assets	Estimated annual amortization expense for finite-lived intangible assets subsequent to September 30, 2021 is as follows: (in thousands) Amount 2021 (remaining) $10,729 2022 42,619 2023 42,503 2024 40,845 2025 40,621 Thereafter 354,669 Total $531,986

Other Assets (Tables)

Other Assets (Tables)	9 Months Ended
	Sep. 30, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of other assets	The Company’s other assets at September 30, 2021 and December 31, 2020 consisted of the following: (in thousands) September 30, 2021 December 31, 2020 Right-of-use asset $6,066 $6,184 Long-term sales-type lease receivable 2,526 2,821 Other long-term receivable 2,418 3,489 Total other assets $11,010 $12,494

Accrued and Other Current Lia_2

Accrued and Other Current Liabilities (Tables)	9 Months Ended
	Sep. 30, 2021
Payables and Accruals [Abstract]
Accrued and other current liabilities	The Company’s accrued and other current liabilities at September 30, 2021 and December 31, 2020 consisted of the following: (in thousands) September 30, 2021 December 31, 2020 Accrued compensation and benefits $8,847 $7,778 Accrued taxes 8,265 6,649 Lease liability 1,614 1,708 Deferred revenue 1,324 1,474 Accrued rebates payable 2,300 390 Insurance premium financing payable — 695 Severance 912 598 Accrued interest 72 83 Other 4,936 6,601 Total accrued and other current liabilities $28,270 $25,976

Debt (Tables)

Debt (Tables)	9 Months Ended
	Sep. 30, 2021
Debt Disclosure [Abstract]
Schedule of debt, net of unamortized discount and deferred financing fees	The Company’s debt, net of unamortized deferred issuance costs, at September 30, 2021 and December 31, 2020 consisted of the following: (in thousands) September 30, 2021 December 31, 2020 Total term loan outstanding $263,188 $274,313 Unamortized deferred issuance costs (6,915) (8,588) Tecnidex loan outstanding 1,649 2,144 Less: Amounts due within one year 3,326 3,378 Total long-term debt due after one year $254,596 $264,491
Schedule of principal repayments under the term loan	Scheduled principal repayments of the Company's debt subsequent to September 30, 2021 are as follows: (in thousands) Amount 2021 (remaining) $806 2022 3,366 2023 3,120 2024 257,253 2025 292 Total $264,837

Leases (Tables)

Leases (Tables)	9 Months Ended
	Sep. 30, 2021
Leases [Abstract]
Schedule of additional information of operating leases	Additional information regarding the Company's operating leases is as follows: Three Months Ended September 30, Nine Months Ended September 30, (in thousands) 2021 2020 2021 2020 Operating Lease Cost Operating leases $546 $662 $1,649 $1,916 Short-term leases (1) 318 6 732 182 Total lease expense $864 $668 $2,381 $2,098 (1) Leases with an initial term of twelve months or less are not recorded on the balance sheet. Other information on operating leases: Nine Months Ended September 30, 2021 2020 Cash payments included in operating cash flows $1,689 $1,645 Right-of-use assets obtained in exchange for new lease $1,665 $769 Weighted average discount rate 8.39 % 9.11 % Weighted average remaining lease term in years 5.5 years 5.1 years
Schedule of maturities of lease liabilities	The following table presents the contractual maturities of the Company's lease liabilities as of September 30, 2021. (in thousands) Lease Liability Remainder of 2021 $568 2022 1,974 2023 1,603 2024 941 2025 754 Thereafter 2,161 Total undiscounted lease payments 8,001 Less: present value adjustment 1,759 Operating lease liability $6,242

Other Noncurrent Liabilities (T

Other Noncurrent Liabilities (Tables)	9 Months Ended
	Sep. 30, 2021
Liabilities, Other than Long-term Debt, Noncurrent [Abstract]
Other noncurrent liabilities	The Company’s other noncurrent liabilities at September 30, 2021 and December 31, 2020 consisted of the following: (in thousands) September 30, 2021 December 31, 2020 Lease liability $4,628 $4,650 Other (1) 1,815 1,782 Total other noncurrent liabilities $6,443 $6,432 (1) Other noncurrent liabilities include long-term rebates and pension liabilities.

Redeemable Non-Controlling In_2

Redeemable Non-Controlling Interest (Tables)	9 Months Ended
	Sep. 30, 2021
Noncontrolling Interest [Abstract]
Temporary equity	The following table summarizes the changes to the Company's Redeemable non-controlling interest. (in thousands) September 30, 2021 December 31, 2020 Beginning balance ($8,446) ($7,701) Net loss attributable to redeemable non-controlling interest 932 394 Adjustment of NCI to redemption value (491) (1,139) Ending balance ($8,005) ($8,446) Series B-1 Convertible Preferred Stock Series B-2 Convertible Preferred Stock Series B Convertible Preferred Stock (in thousands) Shares Amount Shares Amount Shares Amount Balance at December 31, 2019 — $— — $— — $— Issuance of preferred stock 150 150,000 150 — — — Exchange to Series B preferred stock (150) (150,000) (150) — 150 150,000 Issuance-related expenses — — — — — (11,516) In kind dividend — — — — — 5,244 Balance at December 31, 2020 — — — — 150 143,728 Redemption of shares — — — — (5) (5,330) In kind dividend — — — — — 8,610 Balance at September 30, 2021 — $— — $— 145 $147,008

Series B Convertible Preferre_2

Series B Convertible Preferred Stock and Stockholders' Equity (Tables)	9 Months Ended
	Sep. 30, 2021
Stockholders' Equity Note [Abstract]
Change in Series B Preferred Stock	The following table summarizes the changes to the Company's Redeemable non-controlling interest. (in thousands) September 30, 2021 December 31, 2020 Beginning balance ($8,446) ($7,701) Net loss attributable to redeemable non-controlling interest 932 394 Adjustment of NCI to redemption value (491) (1,139) Ending balance ($8,005) ($8,446) Series B-1 Convertible Preferred Stock Series B-2 Convertible Preferred Stock Series B Convertible Preferred Stock (in thousands) Shares Amount Shares Amount Shares Amount Balance at December 31, 2019 — $— — $— — $— Issuance of preferred stock 150 150,000 150 — — — Exchange to Series B preferred stock (150) (150,000) (150) — 150 150,000 Issuance-related expenses — — — — — (11,516) In kind dividend — — — — — 5,244 Balance at December 31, 2020 — — — — 150 143,728 Redemption of shares — — — — (5) (5,330) In kind dividend — — — — — 8,610 Balance at September 30, 2021 — $— — $— 145 $147,008

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Sep. 30, 2021
Earnings Per Share [Abstract]
Reconciliation of weighted average shares outstanding	The following is a reconciliation of the weighted-average common shares outstanding used for the computation of basic and diluted net loss per common share: Three Months Ended September 30, Nine Months Ended September 30, (in thousands) 2021 2020 2021 2020 Basic weighted-average common shares outstanding 51,583 51,002 51,323 50,766 Effect of dilutive options, restricted stock, and restricted stock units — — — — Diluted weighted-average shares outstanding 51,583 51,002 51,323 50,766
Amounts that could potentially dilute basic earnings per share	The following represents the weighted average number of shares that could potentially dilute basic earnings per share in the future: Three Months Ended September 30, Nine Months Ended September 30, (in thousands) 2021 2020 2021 2020 Convertible preferred stock 31,242 21,527 30,955 7,228 Stock-based compensation awards (1) : Stock options 1,446 800 1,114 804 Restricted stock awards and restricted stock units 3,790 1,811 3,214 1,079 Warrants: Private placement warrants — 2,076 — 4,789 Public warrants — 3,310 — 7,636 (1) SARs and Phantom stocks are payable in cash so will therefore have no impact on number of shares.

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
	Sep. 30, 2021
Segment Reporting [Abstract]
Schedule of revenue by segment	The following table presents a breakdown of our revenues and gross profit based on reportable segments for the three and nine months ended September 30, 2021 and 2020. Three Months Ended September 30, Nine Months Ended September 30, (in thousands) 2021 2020 2021 2020 AgroFresh Core Revenues $44,815 $49,343 $96,438 $94,723 Gross Profit 33,078 38,283 74,843 73,080 Tecnidex Revenues 4,363 3,427 13,656 11,052 Gross Profit 1,065 976 2,798 4,203 Total Revenues $49,178 $52,770 $110,094 $105,775 Total Gross Profit $34,143 $39,259 $77,641 $77,283

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2021
Fair Value Disclosures [Abstract]
Tabular disclosure of financial instruments measured at fair value on a recurring basis	The following table presents the fair value of the Company's financial instruments that are measured at fair value on a recurring basis as of September 30, 2021. (in thousands) Level 3 Liability-classified stock compensation (1) $198 The following table presents the fair value of the Company's financial instruments that are measured at fair value on a recurring basis as of December 31, 2020. (in thousands) Level 3 Liability-classified stock compensation (1) $282 (1) The fair values of performance-based phantom shares granted in 2019 and 2020 were estimated using a Monte Carlo simulation pricing model with the assumptions described below: September 30, 2021 Grant date fair value $1.70 — $7.28 Risk-free interest rate 0.27% — 2.39% Expected life (years) 2.71 — 2.75 Estimated volatility factor 65.1% — 69.9% Expected dividends None
Changes in financial instruments measured at level 3 fair value on a recurring basis	The following table presents the changes during the periods presented in our Level 3 financial instruments that are measured at fair value on a recurring basis. (in thousands) Liability-classified stock compensation Balance, December 31, 2020 $282 Stock compensation activity (84) Balance, September 30, 2021 $198

Description of Business (Detail

Description of Business (Details)	9 Months Ended
	Sep. 30, 2021storageRoomcountry
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of operating countries (over) | country	50
Number of storage rooms (over) | storageRoom	25,000

Basis of Presentation and Sum_4

Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details) - USD ($) $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Concentration Risk [Line Items]
Amounts reclassified from unbilled revenue to accounts receivable	$ (9,900)		$ (13,800)
Amounts reclassified from deferred revenue to revenue	(3,900)
Deductions from deferred revenue	$ (3,911)		$ (5,049)
Argentina | Geographic concentration risk | Revenue from contract with customer
Concentration Risk [Line Items]
Concentration risk percentage (as a precent)	5.00%
Argentina | Geographic concentration risk | Revenue benchmark
Concentration Risk [Line Items]
Concentration risk percentage (as a precent)		6.00%
Subsidiaries | Argentina
Concentration Risk [Line Items]
Net assets	$ (5,400)

Basis of Presentation and Sum_5

Basis of Presentation and Summary of Significant Accounting Policies - Summary of Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Disaggregation of Revenue [Line Items]
Total Revenues	$ 49,178	$ 52,770	$ 110,094	$ 105,775
North America
Disaggregation of Revenue [Line Items]
Total Revenues	18,721	17,846	21,470	20,520
EMEA
Disaggregation of Revenue [Line Items]
Total Revenues	26,597	32,032	45,729	47,573
Latin America
Disaggregation of Revenue [Line Items]
Total Revenues	2,244	1,630	29,955	25,905
Asia Pacific
Disaggregation of Revenue [Line Items]
Total Revenues	1,616	1,262	12,940	11,777
Products transferred at a point in time
Disaggregation of Revenue [Line Items]
Total Revenues	48,718	52,169	108,279	103,586
Products transferred at a point in time | North America
Disaggregation of Revenue [Line Items]
Total Revenues	18,603	17,663	20,958	19,823
Products transferred at a point in time | EMEA
Disaggregation of Revenue [Line Items]
Total Revenues	26,468	31,921	45,131	46,887
Products transferred at a point in time | Latin America
Disaggregation of Revenue [Line Items]
Total Revenues	2,064	1,420	29,416	25,338
Products transferred at a point in time | Asia Pacific
Disaggregation of Revenue [Line Items]
Total Revenues	1,583	1,165	12,774	11,538
Services transferred over time
Disaggregation of Revenue [Line Items]
Total Revenues	460	601	1,815	2,189
Services transferred over time | North America
Disaggregation of Revenue [Line Items]
Total Revenues	118	183	512	697
Services transferred over time | EMEA
Disaggregation of Revenue [Line Items]
Total Revenues	129	111	598	686
Services transferred over time | Latin America
Disaggregation of Revenue [Line Items]
Total Revenues	180	210	539	567
Services transferred over time | Asia Pacific
Disaggregation of Revenue [Line Items]
Total Revenues	33	97	166	239
1-MCP based
Disaggregation of Revenue [Line Items]
Total Revenues	43,313	48,038	91,993	91,242
1-MCP based | North America
Disaggregation of Revenue [Line Items]
Total Revenues	17,677	17,122	20,020	19,264
1-MCP based | EMEA
Disaggregation of Revenue [Line Items]
Total Revenues	23,286	28,906	34,083	37,223
1-MCP based | Latin America
Disaggregation of Revenue [Line Items]
Total Revenues	781	845	25,145	23,217
1-MCP based | Asia Pacific
Disaggregation of Revenue [Line Items]
Total Revenues	1,569	1,165	12,745	11,538
Fungicides, disinfectants and coatings
Disaggregation of Revenue [Line Items]
Total Revenues	5,382	4,120	15,804	11,934
Fungicides, disinfectants and coatings | North America
Disaggregation of Revenue [Line Items]
Total Revenues	917	534	931	534
Fungicides, disinfectants and coatings | EMEA
Disaggregation of Revenue [Line Items]
Total Revenues	3,182	3,011	11,044	9,650
Fungicides, disinfectants and coatings | Latin America
Disaggregation of Revenue [Line Items]
Total Revenues	1,283	575	3,829	1,750
Fungicides, disinfectants and coatings | Asia Pacific
Disaggregation of Revenue [Line Items]
Total Revenues	0	0	0	0
Other
Disaggregation of Revenue [Line Items]
Total Revenues	483	612	2,297	2,599
Other | North America
Disaggregation of Revenue [Line Items]
Total Revenues	127	190	519	722
Other | EMEA
Disaggregation of Revenue [Line Items]
Total Revenues	129	115	602	700
Other | Latin America
Disaggregation of Revenue [Line Items]
Total Revenues	180	210	981	938
Other | Asia Pacific
Disaggregation of Revenue [Line Items]
Total Revenues	$ 47	$ 97	$ 195	$ 239

Basis of Presentation and Sum_6

Basis of Presentation and Summary of Significant Accounting Policies - Summary of Contract Assets and Liabilities (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Contract assets:
Beginning balance	$ 1,484	$ 1,666
Additions	11,850	13,624
Deductions	(9,855)	(13,806)
Ending balance	3,479	1,484
Contract liabilities:
Beginning balance	1,474	1,175
Additions	3,761	5,348
Deductions	(3,911)	(5,049)
Ending balance	$ 1,324	$ 1,474

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	9 Months Ended
	Sep. 30, 2021	Jun. 13, 2020
Other affiliates | Investment agreement
Related party transactions
Percent of board required for right to designate directors (as a percent)		50.00%
Percent ownership interest required to designate directors (as a percent)		20.00%
Director | Mutal services agreement
Related party transactions
Expenses paid per service agreement	$ 0

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Inventory Disclosure [Abstract]
Raw material	$ 2,926	$ 3,100
Work-in-process	4,567	7,079
Finished goods	13,015	13,288
Supplies	826	1,112
Total inventories	$ 21,334	$ 24,579

Other Current Assets (Details)

Other Current Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
VAT receivable	$ 10,945	$ 9,348
Income tax receivable	8,137	4,716
Prepaid and other current assets	4,349	3,155
Total other current assets	$ 23,431	$ 17,219

Property and Equipment (Details

Property and Equipment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 24,283		$ 24,283		$ 22,574
Less: accumulated depreciation	(12,342)		(12,342)		(10,142)
Total property and equipment, net	11,941		11,941		12,432
Depreciation expense	700	$ 700	2,000	$ 1,900
Buildings and leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	7,019		$ 7,019		6,416
Buildings and leasehold improvements | Minimum
Property, Plant and Equipment [Line Items]
Useful life (years)			7 years
Buildings and leasehold improvements | Maximum
Property, Plant and Equipment [Line Items]
Useful life (years)			20 years
Machinery & equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	13,115		$ 13,115		11,981
Machinery & equipment | Minimum
Property, Plant and Equipment [Line Items]
Useful life (years)			1 year
Machinery & equipment | Maximum
Property, Plant and Equipment [Line Items]
Useful life (years)			12 years
Furniture
Property, Plant and Equipment [Line Items]
Property and equipment, gross	2,964		$ 2,964		3,031
Furniture | Minimum
Property, Plant and Equipment [Line Items]
Useful life (years)			1 year
Furniture | Maximum
Property, Plant and Equipment [Line Items]
Useful life (years)			12 years
Construction in progress
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 1,185		$ 1,185		$ 1,146

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Schedule of Goodwill (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Goodwill [Roll Forward]
Beginning balance	$ 6,925	$ 6,323
Foreign currency translation	(356)	602
Ending balance	$ 6,569	$ 6,925

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2020
Other intangible assets:
Gross carrying amount, finite-lived	$ 833,127		$ 828,297
Gross carrying amount, indefinite-lived	25,400		29,343
Total intangible assets	858,527		857,640
Accumulated Amortization	(301,141)	$ (268,439)	(268,439)
Total	531,986		559,858
Net, indefinite-lived intangible assets	25,400		29,343
Total intangible assets, net	557,386		589,201
Trade name
Other intangible assets:
Gross carrying amount, indefinite-lived	23,400		27,343
Net, indefinite-lived intangible assets	23,400		27,343
Service provider network
Other intangible assets:
Gross carrying amount, indefinite-lived	2,000		2,000
Net, indefinite-lived intangible assets	2,000		2,000
Developed technology
Other intangible assets:
Gross carrying amount, finite-lived	798,198		798,260
Accumulated Amortization	(283,880)		(254,629)
Total	514,318		543,631
Customer relationships
Other intangible assets:
Gross carrying amount, finite-lived	20,145		19,072
Accumulated Amortization	(6,835)		(4,042)
Total	13,310		15,030
Software
Other intangible assets:
Gross carrying amount, finite-lived	10,946		10,865
Accumulated Amortization	(9,965)		(9,693)
Total	981		1,172
Trade name
Other intangible assets:
Gross carrying amount, finite-lived	3,738		0
Accumulated Amortization	(374)		0
Total	3,364		0
Other
Other intangible assets:
Gross carrying amount, finite-lived	100		100
Accumulated Amortization	(87)		(75)
Total	$ 13		$ 25

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Jun. 30, 2021	Dec. 31, 2020
Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]
Gross carrying amount, finite-lived	$ 833,127		$ 833,127			$ 828,297
Amortization expense	301,141		301,141		$ 268,439	268,439
Amortization of intangibles	10,830	$ 10,973	$ 32,092	$ 32,866
Weighted average
Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]
Useful life (in years)			13 years 7 months 6 days
Trade name
Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]
Gross carrying amount, finite-lived	3,738		$ 3,738			0
Amortization expense	374		$ 374			0
Trade name | Weighted average
Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]
Useful life (in years)			2 years 3 months 18 days
Trade name | Tecnidex
Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]
Useful life (in years)			2 years 6 months
Developed technology
Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]
Gross carrying amount, finite-lived	798,198		$ 798,198			798,260
Amortization expense	283,880		$ 283,880			254,629
Developed technology | Weighted average
Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]
Useful life (in years)			13 years 9 months 18 days
Customer relationships
Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]
Gross carrying amount, finite-lived	20,145		$ 20,145			19,072
Amortization expense	6,835		$ 6,835			4,042
Customer relationships | Weighted average
Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]
Useful life (in years)			10 years 8 months 12 days
Software
Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]
Gross carrying amount, finite-lived	10,946		$ 10,946			10,865
Amortization expense	9,965		$ 9,965			9,693
Software | Weighted average
Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]
Useful life (in years)			2 years 1 month 6 days
Other
Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]
Gross carrying amount, finite-lived	100		$ 100			100
Amortization expense	$ 87		$ 87			$ 75
Other | Weighted average
Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]
Useful life (in years)			9 months 18 days

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets - Future Amortization (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Estimated annual amortization expense
2021 (remaining)	$ 10,729
2022	42,619
2023	42,503
2024	40,845
2025	40,621
Thereafter	354,669
Total	$ 531,986	$ 559,858

Other Assets (Details)

Other Assets (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Other Assets [Abstract]
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Total other assets	Total other assets
Right-of-use asset	$ 6,066	$ 6,184
Long-term sales-type lease receivable	2,526	2,821
Other long-term receivable	2,418	3,489
Total other assets	11,010	$ 12,494
Other long-term receivable deemed uncollectible, write off	$ 800

Accrued and Other Current Lia_3

Accrued and Other Current Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Payables and Accruals [Abstract]
Accrued compensation and benefits	$ 8,847	$ 7,778
Accrued taxes	8,265	6,649
Lease liability	1,614	1,708
Deferred revenue	1,324	1,474
Accrued rebates payable	2,300	390
Insurance premium financing payable	0	695
Severance	912	598
Accrued interest	72	83
Other	4,936	6,601
Total accrued and other current liabilities	$ 28,270	$ 25,976
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Total accrued and other current liabilities	Total accrued and other current liabilities

Debt - Net of Unamortized Disco

Debt - Net of Unamortized Discounts and Deferred Financing Fees (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020	Jul. 27, 2020
Debt Instrument [Line Items]
Less: Amounts due within one year	$ 3,326	$ 3,378
Total long-term debt due after one year	254,596	264,491
Tecnidex loan outstanding
Debt Instrument [Line Items]
Loans outstanding	1,649	2,144
Term loan
Debt Instrument [Line Items]
Loans outstanding	263,188	274,313	$ 403,800
Unamortized deferred issuance costs	$ (6,915)	$ (8,588)

Debt - Narrative (Details)

Debt - Narrative (Details)	Jul. 27, 2020USD ($)	Jul. 31, 2015USD ($)	Sep. 30, 2018USD ($)	Sep. 30, 2021USD ($)	Mar. 31, 2021USD ($)	Sep. 30, 2020USD ($)	Sep. 30, 2021USD ($)	Sep. 30, 2020USD ($)	Dec. 31, 2020USD ($)	Jul. 31, 2020EUR (€)	May 31, 2020EUR (€)	Mar. 31, 2020EUR (€)
Credit facility
Interest rate (as a percent)				7.25%			7.25%
Amortization of deferred financing costs							$ 1,772,000	$ 2,342,000
Long term debt, gross				$ 264,837,000			264,837,000
Interest rate swap
Credit facility
Cash flow hedge, gain (loss)			$ 4,000,000
Derivative financial instruments, liabilities | Interest rate swap
Credit facility
Unrealized gain (loss)						$ 300,000		(400,000)
Maximum
Credit facility
Commitment fee percentage (as a percent)	0.50%
Minimum
Credit facility
Commitment fee percentage (as a percent)	0.375%
Eurodollar
Credit facility
Margin of interest (as a percent)	6.25%
Eurodollar | Maximum
Credit facility
Margin of interest (as a percent)	6.25%
Eurodollar | Minimum
Credit facility
Margin of interest (as a percent)	6.00%
Base rate
Credit facility
Margin of interest (as a percent)	5.25%
Revolving loan
Credit facility
Maximum borrowing available	$ 25,000,000
Debt issuance costs incurred	500,000	$ 1,300,000
Long term debt, gross				0			0
Term loan
Credit facility
Face amount	275,000,000	425,000,000		263,200,000			263,200,000			€ 600,000	€ 300,000	€ 1,000,000
Interest rate (as a percent)										2.50%	2.20%	1.50%
Prepayment of principal					$ 9,100,000
Extinguishment of debt	107,100,000
Loan balance	403,800,000			263,188,000			263,188,000		$ 274,313,000
Modification of debt	296,700,000
Write off of deferred debt issuance cost	700,000
Unamortized issuance costs	1,900,000
Debt issuance costs incurred	7,500,000	$ 12,900,000
Amortization of deferred financing costs						$ 200,000	300,000	$ 1,400,000
Deferred issuance costs, net				6,915,000			6,915,000		$ 8,588,000
Long term debt, gross				0			0
Fair value of debt				263,800,000			263,800,000
Amortization per year (as a percent)		1.00%
Term loan | Amended Credit Facility
Credit facility
Debt issuance costs incurred	6,400,000
Amortization of deferred financing costs				$ 600,000			$ 1,700,000
Term loan | Existing lenders
Credit facility
Write off of deferred debt issuance cost	4,400,000
Term loan | New lenders
Credit facility
Debt issuance costs incurred	1,100,000
Bridge loan
Credit facility
Maximum borrowing available	5,000,000
Letter-of-credit sub-facility
Credit facility
Maximum borrowing available	$ 10,000,000	$ 10,000,000
Credit facility | Alternate base rate
Credit facility
Margin of interest (as a percent)		3.75%
Credit facility | LIBOR
Credit facility
Margin of interest (as a percent)		4.75%
Variable rate base minimum (as a percent)		1.00%

Debt - Principal Repayments (De

Debt - Principal Repayments (Details) $ in Thousands	Sep. 30, 2021USD ($)
Schedule of principal repayments under the Term Loan
2021 (remaining)	$ 806
2022	3,366
2023	3,120
2024	257,253
2025	292
Total	$ 264,837

Leases - Additional Information

Leases - Additional Information on Operating Leases (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Lease, Cost [Abstract]
Operating leases	$ 546	$ 662	$ 1,649	$ 1,916
Short-term lease	318	6	732	182
Total lease expense	$ 864	$ 668	2,381	2,098
Cash payments included in operating cash flows			1,689	1,645
Right-of-use assets obtained in exchange for new lease			$ 1,665	$ 769
Weighted average discount rate (in percent)	8.39%	9.11%	8.39%	9.11%
Weighted average remaining lease term (in years)	5 years 6 months	5 years 1 month 6 days	5 years 6 months	5 years 1 month 6 days

Leases - Maturities of Lease Li

Leases - Maturities of Lease Liabilities: Current Period (Details) $ in Thousands	Sep. 30, 2021USD ($)
Leases [Abstract]
Remainder of 2021	$ 568
2022	1,974
2023	1,603
2024	941
2025	754
Thereafter	2,161
Total undiscounted lease payments	8,001
Less: present value adjustment	1,759
Operating lease liability	$ 6,242

Other Noncurrent Liabilities (D

Other Noncurrent Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Liabilities, Other than Long-term Debt, Noncurrent [Abstract]
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Total other noncurrent liabilities	Total other noncurrent liabilities
Lease liability	$ 4,628	$ 4,650
Other	1,815	1,782
Total other noncurrent liabilities	$ 6,443	$ 6,432

Severance (Details)

Severance (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Compensation Related Costs [Abstract]
Severance expense	$ 0	$ 0.4	$ 1.6	$ 0.5
Severance liability, current	$ 0.9		$ 0.9		$ 0.6

Redeemable Non-Controlling In_3

Redeemable Non-Controlling Interest - Narrative (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 01, 2017
Noncontrolling Interest [Line Items]
Redeemable non-controlling interest	$ 8,005	$ 8,446	$ 7,701
Tecnidex Fruit Protection, S.A.U. | Option agreement
Noncontrolling Interest [Line Items]
Ownership percentage by noncontrolling owners (as a percent)				25.00%
Tecnidex Fruit Protection, S.A.U.
Noncontrolling Interest [Line Items]
Percentage of voting interests acquired (as a percent)				75.00%

Redeemable Non-Controlling In_4

Redeemable Non-Controlling Interest - Changes in Redeemable Non-controlling Interest (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Increase (Decrease) in Temporary Equity [Roll Forward]
Beginning balance	$ (8,446)	$ (7,701)
Net loss attributable to redeemable non-controlling interest	932	394
Adjustment of NCI to redemption value	(491)	(1,139)
Ending balance	$ (8,005)	$ (8,446)

Series B Convertible Preferre_3

Series B Convertible Preferred Stock and Stockholders' Equity (Details)	Jun. 13, 2020USD ($)$ / sharesshares	Jul. 31, 2015directorshares	Sep. 30, 2021USD ($)$ / sharesshares	Sep. 30, 2020USD ($)	Sep. 30, 2021USD ($)vote$ / sharesshares	Sep. 30, 2020USD ($)	Dec. 31, 2015shares	Dec. 31, 2020USD ($)$ / sharesshares	Jul. 31, 2020$ / sharesshares	Dec. 31, 2018USD ($)	Feb. 28, 2014shares
Class of Warrant or Right [Line Items]
Preferred stock, par value (in dollars per share) | $ / shares			$ 0.0001		$ 0.0001			$ 0.0001
Preferred stock, shares outstanding (in shares)			1		1			1
Authorized common stock (in shares)			400,000,000		400,000,000			400,000,000
Par value of common stock (in dollars per share) | $ / shares			$ 0.0001		$ 0.0001			$ 0.0001
Number of votes entitled by holders of common stock for each share of common stock | vote					1
Common stock, shares outstanding (in shares)			52,339,000		52,339,000			52,431,000
Number of shares issuable upon exercise of warrants (in shares)									16,000,000
Exercise price (in dollars per share) | $ / shares									$ 11.50
Number of warrants outstanding (in shares)											16,000,000
Rohm and Haas
Class of Warrant or Right [Line Items]
Number of shares of Series A Preferred Stock issued as condition to consummation of business combination (in shares)		1
Number of directors preferred stockholder is entitled to appoint if minimum ownership percentage of common stock is maintained | director		1
Minimum percentage of outstanding shares of voting and non-voting common stock to be held to entitle preferred stockholder to appoint director (as a percent)		10.00%
Series B Convertible Stock
Class of Warrant or Right [Line Items]
Accrued dividends | $			$ 0		$ 0			$ 0
Preferred stock, convertible, conversion price (in dollars per share) | $ / shares	$ 5
Series B Convertible Stock | Maximum
Class of Warrant or Right [Line Items]
Preferred stock issued (in shares)			31,700,000		31,700,000			31,000,000
Series B Convertible Stock | Paid in-kind
Class of Warrant or Right [Line Items]
Dividends | $			$ 2,300,000	$ 2,200,000	$ 8,600,000	$ 2,200,000
Series B Convertible Stock | Cash
Class of Warrant or Right [Line Items]
Dividends | $			$ 3,900,000	$ 2,200,000	$ 10,000,000	$ 2,200,000
Series B-1 Convertible Preferred Stock
Class of Warrant or Right [Line Items]
Preferred stock, shares outstanding (in shares)			0		0
Series B-2 Convertible Preferred Stock
Class of Warrant or Right [Line Items]
Preferred stock, shares outstanding (in shares)			0		0
Private placement warrants
Class of Warrant or Right [Line Items]
Dividend rate increase (as a percent)	2.00%
Number of warrants outstanding (in shares)											6,200,000
Private placement warrants | Dividends within first anniversary
Class of Warrant or Right [Line Items]
Percentage payable in cash (as a percent)	50.00%
Percentage payable in kind (as a percent)	50.00%
Private placement warrants | Dividends after first anniversary
Class of Warrant or Right [Line Items]
Percentage payable in cash (as a percent)	50.00%
Percentage payable in kind (as a percent)	37.50%
Percentage payable in cash or kind (as a percent)	12.50%
Private placement warrants | Convertible preferred stock
Class of Warrant or Right [Line Items]
Sale of stock, consideration received on transaction | $	$ 150,000,000
Private placement warrants | Series B Convertible Stock
Class of Warrant or Right [Line Items]
Preferred stock issued (in shares)	150,000
Preferred stock, par value (in dollars per share) | $ / shares	$ 0.0001
Convertible preferred stock, shares issued upon conversion (in shares)	150,000
Liquidation preference (in dollars per share) | $ / shares	$ 1,000
Cumulative dividend rate (as a percent)	16.00%
Private placement warrants | Series B-1 Convertible Preferred Stock
Class of Warrant or Right [Line Items]
Preferred stock issued (in shares)	150,000
Preferred stock, par value (in dollars per share) | $ / shares	$ 0.0001
Liquidation preference (in dollars per share) | $ / shares	$ 1,000
Cumulative dividend rate (as a percent)	16.00%
Private placement warrants | Series B-2 Convertible Preferred Stock
Class of Warrant or Right [Line Items]
Preferred stock issued (in shares)	150,000
Preferred stock, par value (in dollars per share) | $ / shares	$ 0.0001
Public warrants
Class of Warrant or Right [Line Items]
Number of warrants outstanding (in shares)											9,800,000
Number of warrants repurchased (in shares)							1,200,000
ATM Facility
Class of Warrant or Right [Line Items]
Maximum aggregate offering of common stock | $										$ 30,000,000

Series B Convertible Preferre_4

Series B Convertible Preferred Stock and Stockholders' Equity - Temporary Equity (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Temporary Equity [Line Items]
Balance at beginning of period	$ 143,728
Balance at end of period	$ 147,008	$ 143,728
Series B Convertible Stock
Temporary Equity [Line Items]
Balance at beginning of period (in shares)	150,000	0
Balance at beginning of period	$ 143,728	$ 0
Issuance of preferred stock (in shares)		0
Issuance of preferred stock		$ 0
Exchange to Series B preferred stock (in shares)		150,000
Exchange to Series B preferred stock		$ 150,000
Redemption of shares	$ 5,330	11,516
In kind dividend		$ 5,244
Redemption of shares (in shares)	4,954
Additional preferred shares (in shares)	0
In kind dividend	$ 8,610
Balance at end of period (in shares)	145,000	150,000
Balance at end of period	$ 147,008	$ 143,728
Series B-1 Convertible Preferred Stock
Temporary Equity [Line Items]
Balance at beginning of period (in shares)	0	0
Balance at beginning of period	$ 0	$ 0
Issuance of preferred stock (in shares)		150,000
Issuance of preferred stock		$ 150,000
Exchange to Series B preferred stock (in shares)		(150,000)
Exchange to Series B preferred stock		$ (150,000)
Redemption of shares	$ 0	0
In kind dividend		$ 0
Additional preferred shares (in shares)	0
In kind dividend	$ 0
Balance at end of period (in shares)	0	0
Balance at end of period	$ 0	$ 0
Series B-2 Convertible Preferred Stock
Temporary Equity [Line Items]
Balance at beginning of period (in shares)	0	0
Balance at beginning of period	$ 0	$ 0
Issuance of preferred stock (in shares)		150,000
Issuance of preferred stock		$ 0
Exchange to Series B preferred stock (in shares)		(150,000)
Exchange to Series B preferred stock		$ 0
Redemption of shares	$ 0	0
In kind dividend		$ 0
Additional preferred shares (in shares)	0
In kind dividend	$ 0
Balance at end of period (in shares)	0	0
Balance at end of period	$ 0	$ 0

Stock-based Compensation - Narr

Stock-based Compensation - Narrative (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended		9 Months Ended
	Jun. 30, 2019	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Aug. 31, 2021	Jul. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares authorized (in shares)							13,700,000
Stock-based compensation expense		$ 1	$ 0.9	$ 2.1	$ 2.7
Share-based compensation, nonvested awards, compensation cost not yet recognized		$ 7		$ 7
Period for recognition of compensation on unvested stock option (in years)				2 years 2 months 12 days
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares authorized (in shares)						1,300,000
ESPP | Employee Stock Purchase Plan 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Discount from market price, purchase date (as a percent)	15.00%
Purchase period (in month)	6 months
ESPP purchase price of common stock, percent of closing price (as a percent)	85.00%
Shares issued (in shares)				406,476

Earnings Per Share - Reconcilia

Earnings Per Share - Reconciliation of Weighted Average Common Shares Outstanding (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Earnings Per Share [Abstract]
Basic (in shares)	51,583,000	51,002,000	51,323,000	50,766,000
Effect of dilutive options, performance stock units and restricted stock (in shares)	0	0	0	0
Diluted (in shares)	51,583,000	51,002,000	51,323,000	50,766,000

Earnings Per Share - Weighted a

Earnings Per Share - Weighted average number of shares that could dilute basic EPS (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Convertible preferred stock
Earnings Per Share [Line Items]
Antidilutive securities (in shares)	31,242	21,527	30,955	7,228
Stock options
Earnings Per Share [Line Items]
Antidilutive securities (in shares)	1,446	800	1,114	804
Restricted stock awards and restricted stock units
Earnings Per Share [Line Items]
Antidilutive securities (in shares)	3,790	1,811	3,214	1,079
Warrants | Private placement warrants
Earnings Per Share [Line Items]
Antidilutive securities (in shares)	0	2,076	0	4,789
Warrants | Public warrants
Earnings Per Share [Line Items]
Antidilutive securities (in shares)	0	3,310	0	7,636

Income Taxes (Details)

Income Taxes (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Tax Disclosure [Abstract]
Effective tax rate	20.40%	955.50%	(35.60%)	(147.90%)

Segment Information (Details)

Segment Information (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021USD ($)	Sep. 30, 2020USD ($)	Sep. 30, 2021USD ($)segment	Sep. 30, 2020USD ($)
Segment Reporting, Disclosure of Entity's Reportable Segments [Abstract]
Number of operating segments | segment			2
Number of reportable segments | segment			2
Net sales	$ 49,178	$ 52,770	$ 110,094	$ 105,775
Gross Profit	34,143	39,259	77,641	77,283
AgroFresh Core
Segment Reporting, Disclosure of Entity's Reportable Segments [Abstract]
Net sales	44,815	49,343	96,438	94,723
Gross Profit	33,078	38,283	74,843	73,080
Tecnidex
Segment Reporting, Disclosure of Entity's Reportable Segments [Abstract]
Net sales	4,363	3,427	13,656	11,052
Gross Profit	$ 1,065	$ 976	$ 2,798	$ 4,203

Commitment and Contingencies (D

Commitment and Contingencies (Details) - Unfavorable regulatory action $ in Millions	Oct. 14, 2019USD ($)
Loss Contingencies [Line Items]
Damages awarded	$ 31.1
Reduction of damages awarded	$ 18

Fair Value Measurements - Finan

Fair Value Measurements - Financial Instruments Measured on a Recurring Basis (Details) - USD ($)	9 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Phantom Stock Units
Financial instruments measured at fair value on a recurring basis
Expected dividends	$ 0
Minimum | Phantom Stock Units
Financial instruments measured at fair value on a recurring basis
Grant date fair value (in dollars per share)	$ 1.70
Risk free interest rate (as a percent)	0.27%
Expected life (years)	2 years 8 months 15 days
Estimated volatility factor (as a percent)	65.10%
Maximum | Phantom Stock Units
Financial instruments measured at fair value on a recurring basis
Grant date fair value (in dollars per share)	$ 7.28
Risk free interest rate (as a percent)	2.39%
Expected life (years)	2 years 9 months
Estimated volatility factor (as a percent)	69.90%
Liability-classified stock compensation | Level 3
Financial instruments measured at fair value on a recurring basis
Fair value of liability	$ 198,000
Liability-classified stock compensation | Recurring | Level 3
Financial instruments measured at fair value on a recurring basis
Fair value of liability	$ 198,000	$ 282,000

Fair Value Measurements - Chang

Fair Value Measurements - Changes of Level 3 Financial Instruments (Details)	9 Months Ended
	Sep. 30, 2021USD ($)
Liability-classified stock compensation | Level 3
Financial instruments measured at Level 3 fair value on a recurring basis rollforward
Stock compensation activity	$ (84,000)
Balance, ending period	198,000
Term loan
Financial instruments measured at Level 3 fair value on a recurring basis
Fair value of debt	263,800,000
Recurring
Financial instruments measured at Level 3 fair value on a recurring basis
Transfers between Level 2 and Level 1	0
Transfers between Level 1 and Level 2	0
Transfers out of level 3	0
Recurring | Liability-classified stock compensation | Level 3
Financial instruments measured at Level 3 fair value on a recurring basis rollforward
Balance, beginning period	282,000
Balance, ending period	$ 198,000

Other Expense (Income) (Details

Other Expense (Income) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Other Income and Expenses [Abstract]
Other income (loss)	$ (299)	$ 96	$ 14,053	$ 1,596

Correction Prior Period Errors

Correction Prior Period Errors - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Redeemable NCI	$ 994	$ (30,053)	$ (7,843)	$ (50,651)
Revision of Prior Period, Error Correction, Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Redeemable NCI		$ 800		$ 1,200